ADD CONDITION
Salicylic acid
Last content change checked dailysee data sync status
- Active ingredient
- Salicylic Acid 0.001 mg/100 mL – 40 g/100 1
- Reference brand
- Cornstick
- Dosage forms
- Aerosol, Spray
- Cloth
- Concentrate
- Cream
- Disc
- Emulsion
- Gel
- Liquid
- Lotion
- Lotion/Shampoo
- Oil
- Ointment
- Paste
- Patch
- Plaster
- Poultice
- Powder
- Rinse
- Soap
- Solution
- Solution/ Drops
- Spray
- Stick
- Strip
- Suspension
- Swab
- System
- Routes
- Auricular (otic)
- Buccal
- Conjunctival
- Cutaneous
- Dental
- Extracorporeal
- Intraepidermal
- Percutaneous
- Topical
- Transdermal
- Prescription status
- OTC (over the counter)
- Marketed in the U.S.
- Since 1967
- Label revision date
- March 24, 2026
- Pregnancy
- See Pregnancy Use Section
- Lactation
- See Lactation Use Section
- Active ingredient
- Salicylic Acid 0.001 mg/100 mL – 40 g/100 1
- Reference brand
- Cornstick
- Dosage forms
- Aerosol, Spray
- Cloth
- Concentrate
- Cream
- Disc
- Emulsion
- Gel
- Liquid
- Lotion
- Lotion/Shampoo
- Oil
- Ointment
- Paste
- Patch
- Plaster
- Poultice
- Powder
- Rinse
- Soap
- Solution
- Solution/ Drops
- Spray
- Stick
- Strip
- Suspension
- Swab
- System
- Routes
- Auricular (otic)
- Buccal
- Conjunctival
- Cutaneous
- Dental
- Extracorporeal
- Intraepidermal
- Percutaneous
- Topical
- Transdermal
- Prescription status
- OTC (over the counter)
- CSA schedule
- Not a scheduled drug
- Marketed in the U.S.
- Since 1967
- Label revision date
- March 24, 2026
- Pregnancy
- See Pregnancy Use Section
- Lactation
- See Lactation Use Section
If you are a healthcare professional or from the pharmaceutical industry please visit this version.
If you are a consumer or patient please visit this version.
Drug Overview
You may be looking for a solution to manage acne, and there are various products available that can help. Many of these treatments contain salicylic acid, which is known for its ability to penetrate pores and effectively treat acne by reducing blemishes, blackheads, and whiteheads. These products are designed to clear excess oil and impurities from the skin, helping to prevent new breakouts from forming while allowing existing acne to heal.
In addition to salicylic acid, some formulations may include other beneficial ingredients like glycolic acid, niacinamide, and natural extracts that soothe the skin and enhance its overall appearance. Whether in the form of gels, creams, washes, or patches, these acne treatments aim to provide you with clearer skin and a more confident complexion.
Uses
You can use this product for the treatment of acne. It helps clear existing acne blemishes and allows your skin to heal. Additionally, it works to prevent new acne blemishes from forming, making it effective for ongoing acne management. Whether you have occasional breakouts or persistent acne, this treatment is designed to help keep your skin clear and healthy.
Dosage and Administration
To use acne treatments effectively, start by cleansing your skin thoroughly. For most products, apply a thin layer to the affected area one to three times daily. If you're new to a product, begin with one application daily and gradually increase to two or three times daily as tolerated. If you experience excessive dryness or peeling, reduce usage to once a day or every other day.
For liquid treatments, wet the area before application, and ensure to rinse thoroughly after use. When using patches for warts or skin tags, clean the area, apply the patch, and follow the specific instructions for removal and reapplication, typically every 48 hours for up to 12 weeks. Always avoid contact with your eyes, and if irritation occurs, discontinue use and consult a healthcare professional.
What to Avoid
You should avoid using these products if you have certain conditions or if specific situations arise. Do not use if you are diabetic or have poor blood circulation, unless advised by a healthcare professional. Additionally, refrain from using these products on irritated, infected, or reddened skin, as well as on moles, birthmarks, genital warts, or warts on the face. If you experience skin irritation or sensitivity, stop using the product and consult a doctor.
Always keep these products out of reach of children, and if swallowed, seek medical help or contact a Poison Control Center immediately. Avoid contact with eyes; if contact occurs, rinse thoroughly with water. When using topical acne medications, limit to one at a time to prevent increased dryness or irritation.
Side Effects
When using topical acne treatments, you should be aware of potential side effects and precautions. Most products are for external use only and can cause skin irritation or dryness, especially if used alongside other acne medications. If you experience excessive irritation, redness, burning, or peeling, discontinue use and consult a doctor.
Additionally, avoid contact with eyes, lips, and mouth; if contact occurs, rinse thoroughly with water. Some products may be flammable, so keep them away from fire or flame. If swallowed, seek medical help immediately. Always keep these products out of reach of children. If you have diabetes or poor blood circulation, consult a healthcare professional before use, as these conditions may increase the risk of adverse reactions.
Warnings and Precautions
These products are for external use only. Avoid contact with eyes; if contact occurs, rinse thoroughly with water.
Skin irritation and dryness may occur, especially if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.
Keep out of reach of children. If swallowed, seek medical help or contact a Poison Control Center immediately.
Do not use if you are diabetic or have poor blood circulation, unless directed by a doctor. Avoid using on irritated, infected, or reddened skin, as well as on moles, birthmarks, genital warts, or warts on the face.
If discomfort persists or worsens, stop using the product and consult a doctor.
Overdose
If you accidentally swallow any acne or wart treatment products, it's important to seek medical help immediately or contact a Poison Control Center. Signs of an overdose may include unusual symptoms, but specific signs are not detailed in the information provided. Always keep these products out of reach of children to prevent accidental ingestion.
For any product that is swallowed, you should act quickly and get professional assistance. Remember, if you have any concerns or experience adverse effects, don't hesitate to reach out for help.
Pregnancy Use
During pregnancy, it's important to be cautious with skincare products, especially those containing salicylic acid, which is commonly found in acne treatments. Salicylic acid is generally contraindicated during pregnancy due to potential risks to the fetus, including the possibility of teratogenic effects (which can cause birth defects). Many products do not have established safety data for use during pregnancy, and it is advised to consult a healthcare provider before using any such products.
If you are pregnant or planning to become pregnant, it is best to avoid products containing salicylic acid unless specifically directed by a healthcare professional. Always discuss any skincare regimen with your doctor to ensure the safety of both you and your baby.
Lactation Use
You may be wondering about the safety of using certain products while breastfeeding. Currently, many products do not provide specific warnings or recommendations for nursing mothers. However, some products indicate a potential for excretion in breast milk, meaning that ingredients could pass into your breast milk and potentially affect your infant.
For products containing salicylic acid, caution is advised, as the effects on nursing infants are not well studied. It is recommended that you consult a healthcare professional before using any product if you are breastfeeding, especially if it is indicated that the safety during lactation has not been established. Always monitor your infant for any adverse reactions if you choose to use these products.
Pediatric Use
You should always keep all medications and treatments out of reach of children to prevent accidental ingestion. If a child swallows any of these products, seek medical help or contact a Poison Control Center immediately.
For products containing salicylic acid, it's important to start with one application daily and gradually increase to two or three times daily if needed, as excessive drying of the skin may occur. If dryness or peeling becomes bothersome, reduce the application frequency. Some products may not be suitable for children under 2 years old, and others may require adult supervision during use. Always consult a healthcare professional if you have concerns about using these products on children.
Geriatric Use
You may find that many acne and wart removal products do not provide specific information regarding their use in older adults. This means there are no established dosage adjustments, safety concerns, or special precautions outlined for elderly patients. If you are an older adult or a caregiver, it is essential to approach these products with caution, especially if you have underlying health conditions or are taking other medications.
Since there are no specific guidelines available, it is advisable to consult with a healthcare professional before using any of these products. They can provide personalized advice based on your health status and needs. Always monitor for any adverse reactions when trying new treatments, and discontinue use if you experience any discomfort or unusual symptoms.
Renal Impairment
If you have kidney problems, it's important to be aware that some medications may require dosage adjustments. For instance, certain acne treatments and cleansers may necessitate a reduced dose, especially if your creatinine clearance is low (a measure of kidney function). Regular monitoring of your renal function is recommended to ensure safety and effectiveness.
Specifically, medications like Herbaglow Baiwoxia Anti-Acne Gel, Oil Free Daily Face, and Perricone Md Acne Relief Maximum Strength Spot Gel highlight the need for careful dosage management and monitoring of kidney function. Always consult with your healthcare provider before starting any new treatment to ensure it is safe for your specific health needs.
Hepatic Impairment
You may be wondering about the safety of using certain products if you have liver issues. Based on the information available, most products do not provide specific guidance regarding liver impairment, dosage adjustments, or monitoring for patients with liver problems. This means that there are no special precautions or changes recommended for those with liver conditions when using these products.
However, there are a couple of exceptions. For instance, one product indicates that hepatic impairment may affect how the drug is processed in your body, suggesting that dosage adjustments might be necessary and that liver function tests should be monitored. If you have liver issues, it's always best to consult with your healthcare provider before using any new products to ensure they are safe for you.
Drug Interactions
When using topical acne treatments, it's important to be cautious about combining products. Using multiple topical acne medications at the same time can lead to increased dryness or irritation of the skin. If you experience irritation, it's advisable to use only one medication at a time unless directed otherwise by your healthcare provider.
Always discuss your medications and any treatments with your healthcare provider to ensure safety and effectiveness, as they can provide personalized advice based on your specific health needs.
Storage and Handling
To ensure the effectiveness and safety of your acne and wart treatment products, store them at room temperature, ideally between 20°C to 25°C (68°F to 77°F). Keep the containers tightly closed to prevent contamination and solidification, and protect them from excessive heat, direct sunlight, and moisture. Avoid freezing any products, as this can compromise their integrity.
After opening, it's important to discard the products after a certain period or if they show signs of deterioration. Always keep these products out of reach of children and avoid contact with fabrics, as some may stain. If you have any concerns about usage or if the product is ingested, seek medical advice immediately.
Uses and Indications
This drug is indicated for the treatment of acne. It helps clear acne blemishes, allows skin to heal, and prevents the formation of new acne blemishes. The formulations are designed to penetrate pores, control acne pimples, and reduce the severity of acne blemishes, including blackheads and whiteheads.
Specific Indications
General Acne Treatment:
For the treatment of acne.
Clears acne blemishes and allows skin to heal.
Helps prevent new acne blemishes, blackheads, and whiteheads from forming.
Dries and clears acne pimples.
Acne Management:
For the management of body acne.
Soothes and clears body breakouts while preventing new acne from forming.
Formulated with salicylic acid to penetrate and clear pores of excess oil and debris.
Limitations of Use
No teratogenic or nonteratogenic effects have been mentioned for any of the formulations.
This drug is suitable for various skin types and can be used in conjunction with other acne treatments as directed.
Dosage and Administration
The recommended dosage and administration for the various topical acne and wart treatments are as follows:
For acne treatments, the products should be applied to clean, dry skin. A thin layer should be covered over the entire affected area one to three times daily, depending on the specific product. New users are advised to start with one application daily and gradually increase to two or three times daily as tolerated. If excessive dryness or peeling occurs, the frequency of application should be reduced to once a day or every other day. It is important to avoid contact with the eyes and to rinse thoroughly if contact occurs.
For spot treatments, a small amount should be applied directly to the blemish or affected area, avoiding the eye area. These can be used one to three times daily, with the same precautions regarding frequency and potential dryness.
For wart treatments, the affected area should be washed and dried thoroughly before application. Depending on the product, a medicated patch or liquid should be applied directly to the wart, with some products recommending a repeat application every 48 hours until the wart is removed. In some cases, soaking the wart in warm water for 5 minutes prior to application may assist in the treatment process.
For all products, it is recommended to conduct a sensitivity test for new users by applying the product to a small area for the first three days. If no discomfort occurs, the user may follow the standard application instructions. Additionally, if going outside after application, sunscreen should be applied to protect the skin.
In summary, the general guidelines for dosage and administration include:
Cleanse the skin thoroughly before application.
Apply a thin layer to the affected area one to three times daily.
Start with one application daily, increasing as tolerated.
Reduce frequency if dryness or peeling occurs.
Avoid contact with eyes and rinse thoroughly if contact occurs.
Conduct a sensitivity test for new users.
These instructions should be followed unless otherwise directed by a healthcare professional.
Contraindications
Use of this product is contraindicated in the following situations:
Patients with diabetes or poor blood circulation, unless under the advice and supervision of a doctor or podiatrist.
Individuals with irritated, infected, or reddened skin.
Application on genital warts, warts on the face, moles, birthmarks, or warts with hair growing from them.
Use on mucous membranes is not recommended.
Do not apply to damaged or broken skin, including cuts, abrasions, eczema, or sunburn.
Individuals with known allergies to any of the ingredients in the product should avoid use.
Pregnant or breastfeeding women should consult a healthcare professional before use.
If skin irritation or sensitivity develops, discontinue use and consult a doctor.
Avoid contact with eyes; if contact occurs, rinse thoroughly with water.
Warnings and Precautions
For external use only.
Serious Warnings
Skin irritation and dryness is more likely to occur if another topical acne medication is used at the same time. If irritation occurs, only one topical acne medication should be used unless directed by a doctor.
Avoid contact with eyes. If contact occurs, flush thoroughly with water.
If swallowed, get medical help or contact a Poison Control Center right away.
General Precautions
Keep out of reach of children.
Do not use on irritated, infected, or reddened skin.
Do not use if you are diabetic or have poor blood circulation, except under the advice and supervision of a doctor or podiatrist.
Do not use on genital warts, warts on the face, moles, birthmarks, or warts with hair growing from them, or on mucous membranes.
If discomfort persists, see your doctor or podiatrist.
Monitoring Requirements
If excessive skin irritation develops or increases, discontinue use and consult a doctor.
If skin irritation occurs or gets worse, stop use and ask a doctor.
Emergency Medical Help
In case of accidental ingestion, get medical help or contact a Poison Control Center immediately.
If symptoms of an allergic reaction occur, such as rash, itching, or swelling, discontinue use and seek medical attention.
Special Considerations
Some individuals may be sensitive to essential oils; begin with a small amount to determine if irritation occurs.
Sunscreen use is recommended with any glycolic acid product and for an additional week thereafter, as some individuals may be more sensitive to sunlight.
Additional Instructions
If using other topical acne medications, limit use to one medication at a time unless directed by a healthcare professional.
Perform a patch test before first use to check for sensitivity.
Side Effects
Patients using topical acne medications may experience a range of adverse reactions, primarily related to skin irritation and dryness. The following summarizes the adverse reactions and warnings associated with various products:
Common Adverse Reactions
Skin Irritation: Patients may experience redness, burning, itching, peeling, or swelling, particularly when using multiple topical acne medications simultaneously. If irritation occurs, it is advised to discontinue use and consult a healthcare professional.
Dryness: Increased dryness of the skin is frequently reported, especially when combined with other topical treatments.
Serious Adverse Reactions
Allergic Reactions: Signs such as rash, itching, or swelling may indicate an allergic reaction. Patients should seek medical advice if these symptoms develop.
Severe Irritation: If skin irritation becomes severe or does not improve after regular use, patients are advised to stop using the product and consult a doctor.
Specific Warnings
For External Use Only: All products are intended for external application only. Contact with eyes, lips, and mucous membranes should be avoided. If contact occurs, the affected area should be flushed with water for 15 minutes.
Flammability: Many products are flammable and should be kept away from fire or flame.
Contraindications:
Do not use on irritated, infected, or reddened skin.
Patients with diabetes or poor blood circulation should consult a healthcare provider before use.
Not recommended for use on genital warts, warts on the face, or moles and birthmarks with hair growing from them.
Recommendations for Use
Single Medication Use: To minimize the risk of irritation, it is recommended that patients use only one topical acne medication at a time unless directed otherwise by a healthcare professional.
Sensitivity Testing: New users are advised to perform a sensitivity test by applying the product to a small area for the first few days to monitor for any adverse reactions.
Additional Notes
Keep Out of Reach of Children: All products should be stored out of reach of children. In case of accidental ingestion, medical help should be sought immediately.
Consultation: Patients are encouraged to consult a healthcare provider if discomfort persists or if they have any concerns regarding the use of these products.
This summary reflects the potential adverse reactions and precautions associated with the use of topical acne treatments, emphasizing the importance of monitoring for side effects and seeking medical advice when necessary.
Drug Interactions
Using multiple topical acne medications simultaneously or immediately after one another may lead to increased dryness or irritation of the skin. If such irritation occurs, it is recommended to use only one topical acne medication at a time unless otherwise directed by a healthcare professional. This caution applies to various products, including those containing salicylic acid and other topical acne treatments.
In particular, skin irritation and dryness are more likely to occur when using multiple topical acne medications concurrently. Therefore, it is advisable to limit the use of these products to one at a time to minimize the risk of adverse effects.
No specific drug interactions or laboratory test interactions have been reported for the majority of the products reviewed. This includes a wide range of topical treatments, gels, creams, and cleansers designed for acne management and wart removal.
Pediatric Use
Pediatric patients should be closely monitored when using topical products, particularly those containing active ingredients such as salicylic acid.
General Safety Information
All products should be kept out of reach of children. In case of accidental ingestion, medical help should be sought immediately, or a Poison Control Center should be contacted.
Specific Considerations
Salicylic Acid Products:
Pediatric use has not been established for many salicylic acid formulations. Safety and effectiveness in pediatric patients have not been determined.
For products containing salicylic acid, excessive drying of the skin may occur. It is recommended to start with one application daily, gradually increasing to two or three times daily as tolerated. If bothersome dryness or peeling occurs, reduce application to once a day or every other day.
Wart Removers:
Children should use wart removal products under adult supervision. Specific formulations may have age restrictions, such as not being suitable for children under 3 years of age or requiring consultation with a doctor for those under 2 years.
BHA-containing Products:
Avoid using BHA-containing products on infants and children.
Application Guidelines
For new users of topical treatments, it is advisable to apply the product sparingly to one or two small affected areas during the first three days. If no discomfort occurs, follow the standard application directions.
If skin irritation or severe dryness occurs, discontinue use and consult a healthcare professional.
Special Precautions
Consult a healthcare professional before using any topical acne treatment in children, especially if they are under 2 years of age or have existing skin conditions.
Geriatric Use
No specific information regarding geriatric use, dosage adjustments, safety concerns, or special precautions for elderly patients is provided across the reviewed drug inserts. Therefore, healthcare professionals should exercise caution when prescribing these products to geriatric patients, considering the potential for altered pharmacokinetics and increased sensitivity to topical agents in this population. Regular monitoring for adverse effects and efficacy is recommended when these products are used in elderly patients.
Pregnancy
The safety of various products containing salicylic acid during pregnancy has not been established. Salicylic acid is generally contraindicated in pregnancy due to potential risks to the fetus, including the possibility of teratogenic effects. Pregnant patients are advised to avoid using products containing salicylic acid unless directed by a healthcare provider.
For products that do not specifically mention pregnancy use, caution is still recommended. Pregnant individuals should consult a healthcare provider before using any of these products, especially those containing salicylic acid, as dosage modifications may be necessary based on individual circumstances.
In summary, the following precautions are recommended for pregnant patients:
Consultation: Pregnant women should consult a healthcare provider before using any product containing salicylic acid or other active ingredients that may pose risks during pregnancy.
Avoidance: It is advised to avoid the use of salicylic acid-containing products unless the potential benefits justify the risks to the fetus.
Monitoring: If use is deemed necessary, close monitoring and possible dosage adjustments should be discussed with a healthcare professional.
Overall, the potential risks associated with the use of salicylic acid during pregnancy necessitate careful consideration and professional guidance.
Lactation
There are no specific warnings or recommendations regarding the use of various products by nursing mothers across the reviewed labels. Most products do not provide information on the potential for excretion in breast milk or any associated risks to breastfed infants.
However, caution is advised for certain products, particularly those containing salicylic acid. For instance, some labels indicate that there is a potential for excretion in breast milk, and nursing mothers should consult a healthcare professional before using these products. The effects on nursing infants are not well studied, and the risks versus benefits should be carefully considered.
In summary, while many products lack specific lactation-related information, nursing mothers are encouraged to seek guidance from healthcare providers when considering the use of these products, especially those with known ingredients that may pose risks during lactation.
Renal Impairment
Patients with renal impairment may require careful consideration when using certain medications. For some products, dosage adjustments may be necessary based on the severity of renal function decline. Specifically, patients with reduced creatinine clearance, particularly those with levels below 30 mL/min, should be closely monitored and may need a reduced dose to avoid potential toxicity.
Regular monitoring of renal function tests is recommended for patients with known kidney problems to ensure safe and effective use of these medications. Special attention should be given to patients with significant renal impairment, as they may be at higher risk for adverse effects.
In summary, while some products do not provide specific guidance regarding renal impairment, those that do emphasize the importance of dosage adjustments and regular monitoring to ensure patient safety.
Hepatic Impairment
Patients with hepatic impairment may experience altered pharmacokinetics of certain medications. Specifically, hepatic impairment can affect the metabolism of drugs, necessitating dosage adjustments.
For some products, such as those containing salicylic acid, there is no specific information provided regarding dosage adjustments, monitoring requirements, or precautions for patients with liver problems. However, for certain medications, it is advised to monitor liver function tests regularly in patients with pre-existing liver conditions.
In particular, caution should be exercised when prescribing to patients with significant hepatic impairment, and a reduced dose may be considered for those with moderate to severe hepatic impairment.
Overall, healthcare providers should evaluate the individual patient's liver function and consider potential adjustments or monitoring as necessary when treating patients with hepatic impairment.
Overdosage
In the event of an overdose, it is crucial to seek medical assistance or contact a Poison Control Center immediately. Symptoms of overdose may vary depending on the specific product ingested, but generally, if any of the products listed are swallowed, medical help should be sought without delay.
For products containing salicylic acid, it is particularly important to monitor for any adverse reactions, as ingestion may lead to complications. The following actions are recommended:
Immediate Action: If any product is swallowed, contact a medical professional or Poison Control Center right away.
Monitoring: Observe for any unusual symptoms or reactions following ingestion, and report these to healthcare providers.
Prevention: Keep all products out of reach of children to prevent accidental ingestion.
Specific products that require immediate medical attention if swallowed include, but are not limited to:
Replenix Gly-Sal 10-2
First Aid Beauty Fab Acne Spot Treatment
Acne Calming Water Cream
Various formulations of salicylic acid in liquid, patch, and gel forms.
It is essential to adhere to these guidelines to ensure safety and effective management in case of an overdose.
Nonclinical Toxicology
Teratogenic Effects
No information regarding teratogenic effects was provided across the reviewed products.
Non-Teratogenic Effects
The reviewed products did not provide specific information on non-teratogenic effects.
Nonclinical Toxicology Section
No relevant nonclinical toxicology information was available for the products assessed.
Animal Pharmacology and Toxicology
The reviewed products did not include any details regarding animal pharmacology and toxicology.
Storage and Handling
Products are supplied in various forms including liquids, gels, creams, patches, and plasters. The following storage and handling instructions apply:
General Storage Conditions: Most products should be stored at room temperature, typically between 20°C to 25°C (68°F to 77°F). Some products may have specific temperature ranges, such as 15°C to 30°C (59°F to 86°F) or controlled room temperature conditions.
Protection from Heat and Light: Many products require protection from excessive heat and direct sunlight. It is essential to keep containers tightly closed to prevent contamination and degradation.
Avoiding Freezing: Products should not be frozen, as this may affect their efficacy.
Upright Storage: Certain liquid products should be stored upright to prevent leakage.
Post-Opening Disposal: Most products should be discarded after opening to ensure safety and effectiveness.
Specific Handling Instructions:
Keep away from fire or flame.
Wipe the tops of bottles clean after each use to prevent contamination.
Avoid contact with fabrics, floors, and countertops, as some products may stain.
For patches, ensure they are stored in a cool, dry place and kept out of reach of children.
Child Safety: All products should be kept out of reach of children, and in case of accidental ingestion, medical help should be sought immediately.
Environmental Considerations: Some products may have specific disposal instructions to minimize environmental impact.
These guidelines ensure the integrity and safety of the products throughout their shelf life.
Product Labels
The table below lists all over-the-counter labels containing salicylic acid. Use it to compare dosage forms, strengths, and uses across products.
More Details | |||||
|---|---|---|---|---|---|
111MedCo LLC | Soap | Topical | 20 mg/1 g | 2022 | |
Indications
| |||||
AAVRANI, INC. | Liquid | Topical | 18 mg/1 mL | 2023 | |
Indications
| |||||
Eminence Organic Skin Care Ltd. | Cream | Topical | 10 mg/1 mL | 2018 | |
Indications
| |||||
Eminence Organic Skin Care Ltd. | Cream | Topical | 5 mg/1 mL | 2018 | |
Indications
| |||||
CLINIQUE LABORATORIES LLC | Lotion | Topical | 10 mg/1 mL | 2016 | |
Indications
| |||||
GLYTONE LLC | Aerosol, Spray | Topical | 30 mg/1 mL | 2024 | |
Indications
| |||||
Dermalogica, LLC. | Lotion | Topical | 0.5 mg/100 mL | 2025 | |
Indications
| |||||
Curology | Soap | Topical | 20 mg/1 mL | 2023 | |
Indications
| |||||
Curology | Soap | Topical | 20 mg/1 mL | 2022 | |
Indications
| |||||
Rejoice International | Gel | Topical | 7 mg/354 mg | 2013 | |
Indications
| |||||
Ganzhou Olivee Cosmetic Co. , Ltd. | Patch | Topical | 0.5 g/100 g | 2025 | |
Indications
| |||||
e. l. f. Cosmetics, Inc. | Cream | Topical | 10 mg/1 mL | 2022 | |
Indications
| |||||
Whole Foods Market | Liquid | Topical | 3.61 g/3.61 g | 2019 | |
| |||||
Whole Foods Market | Lotion | Topical | 1.18 g/1.18 g | 2019 | |
Indications
| |||||
e. l. f. Cosmetics, Inc. | Liquid | Topical | 10 mg/1 mL | 2022 | |
Indications
| |||||
BRANDS INTERNATIONAL | Solution | Topical | 1 mg/100 mL | 2024 | |
Indications
| |||||
Curology | Liquid | Topical | 2 g/100 g | 2025 | |
Indications
| |||||
Spa de Soleil | Liquid | Topical | 1.15 mg/230 mL | 2023 | |
Indications
| |||||
CLINIQUE LABORATORIES LLC | Gel | Topical | 20 mg/1 mL | 2014 | |
Indications
| |||||
GLYTONE LLC | Gel | Topical | 2 g/2 mL | 2024 | |
Indications
| |||||
GLYTONE LLC | Liquid | Topical | 2 mg/1 mL | 2024 | |
Indications
| |||||
Walgreen | Cream | Topical | 2000 mg/100 mL | 2023 | |
Indications
| |||||
Bentley Laboratories, LLC | Gel | Topical | 2.0 g/100 mL | 2024 | |
Indications
| |||||
Walmart Inc. | Liquid | Topical | 20 mg/1 mL | 2025 | |
Indications
| |||||
Bentley Laboratories, LLC | Gel | Topical | 2.0 g/100 mL | 2024 | |
Indications
| |||||
Bentley Laboratories, LLC | Gel | Topical | 2.0 g/100 mL | 2023 | |
Indications
| |||||
Shenzhen Hengkaifeng Commerce and Trade Co. , Ltd | Patch | Topical | 1 g/100 1 | 2024 | |
Indications
| |||||
derma e | Gel | Topical | 20 mg/1 mL | 2015 | |
Indications
| |||||
Pacifica Beauty, LLC | Liquid | Topical | 2 g/100 mL | 2023 | |
| |||||
Merle Norman Cosmetics, Inc | Gel | Topical | 2 g/100 g | 2017 | |
| |||||
Ganzhou Olivee Cosmetic Co. , Ltd. | Patch | Topical | 0.5 g/100 g | 2026 | |
Indications
| |||||
Zhejiang Ayan Biotech Co. , Ltd. | Cream | Topical | 5 mg/1 mL | 2018 | |
Indications
| |||||
e. l. f. Cosmetics, Inc | Cream | Topical | 18 mg/1 g | 2021 | |
Indications
| |||||
e. l. f. Cosmetics, Inc | Gel | Topical | 10 mg/1 mL | 2022 | |
Indications
| |||||
Zhejiang Ayan Biotech Co. , Ltd. | Gel | Topical | 10 mg/1 mL | 2018 | |
Indications
| |||||
AcneFree LLC | Gel | Topical | 20 mg/1 mL | 2018 | |
Indications
| |||||
Tiege Hanley | Gel | Topical | 20 mg/1 mL | 2025 | |
Indications
| |||||
Spa de Soleil | Cream | Topical | 0.5 mg/50 mL | 2023 | |
Indications
| |||||
Allure Labs | Liquid | Topical | 20 mg/1 g | 2022 | |
Indications
| |||||
TT Beauty Trading Co. , Ltd. | Patch | Topical | 0.2 g/100 g | 2025 | |
| |||||
Allure Labs | Cream | Topical | 0.5 g/100 g | 2024 | |
Indications
| |||||
RV Skincare LLC | Gel | Topical | 5 mg/1 mL | 2017 | |
Indications
| |||||
Amazon. com Services LLC | Gel | Topical | 20 mg/1 mL | 2018 | |
Indications
| |||||
Old East Main Co. | Gel | Topical | 21 mg/1 mL | 2015 | |
Indications
| |||||
Spa de Soleil | Liquid | Topical | 1.8 mg/180 mL | 2023 | |
Indications
| |||||
Topco Associates LLC | Cream | Topical | 20 mg/1 mL | 2013 | |
Indications
| |||||
United Natural Foods, Inc. dba UNFI | Gel | Topical | 20 mg/1 mL | 2013 | |
Indications
| |||||
Walmart Inc. | Gel | Topical | 20 mg/1 mL | 2015 | |
Indications
| |||||
Noon Aesthetics M. R. Ltd | Cream | Topical | 0.15 g/30 g | 2020 | |
Indications
| |||||
CLINIQUE LABORATORIES LLC | Gel | Topical | 10 mg/1 mL | 2023 | |
Indications
| |||||
CLINIQUE LABORATORIES LLC | Gel | Topical | 10 mg/1 mL | 2008 | |
Indications
| |||||
CLINIQUE LABORATORIES LLC | Soap | Topical | 2 g/100 g | 2006 | |
Indications
| |||||
CLINIQUE LABORATORIES LLC | Liquid | Topical | 15 mg/1 mL | 2006 | |
Indications
| |||||
CLINIQUE LABORATORIES LLC | Gel | Topical | 20 mg/1 mL | 2025 | |
Indications
| |||||
CLINIQUE LABORATORIES LLC | Liquid | Topical | 5 mg/1 mL | 2020 | |
Indications
| |||||
CLINIQUE LABORATORIES LLC | Cream | Topical | 10 mg/1 mL | 2020 | |
Indications
| |||||
CONTROL CORRECTIVE SKINCARE INC | Gel | Topical | 2 g/100 mL | 2016 | |
Indications
| |||||
CosMedical Technologies | Liquid | Topical | 20 mg/1 mL | 2015 | |
Indications
| |||||
Dime Beauty Co, LLC | Cream | Topical | 2 g/100 mL | 2023 | |
| |||||
Skinfix, Inc. | Cream | Topical | 2 g/100 mL | 2021 | |
Indications
| |||||
PSODEX USA INC | Cream | Topical | 1.5 g/100 mL | 2024 | |
Indications
| |||||
Dime Beauty Co, LLC | Cream | Topical | 2 g/100 mL | 2022 | |
| |||||
Natureplex, LLC | Gel | Topical | 5 mg/1 g | 2007 | |
Indications
| |||||
Guangzhou Yapeng Refinement Chemical Co. , Ltd. | Cloth | Topical | 2 g/100 g | 2025 | |
Indications
| |||||
Guangzhou Yapeng Refinement Chemical Co. , Ltd. | Cream | Topical | 2 g/100 mL | 2025 | |
Indications
| |||||
S+ | Gel | Topical | 20 mg/1 mL | 2022 | |
Indications
| |||||
Young Living Essential Oils, LC | Gel | Topical | 2 g/100 g | 2018 | |
Indications
| |||||
Shenzhen Hengdasheng Technology Co. , Ltd | Patch | Cutaneous | 0.75 U/100 U | 2026 | |
Indications
| |||||
Guangzhou Meiya Cosmetics Co. , Ltd. | Emulsion |
| 0.5 g/1 mg | 2024 | |
| |||||
Pacifica Beauty, LLC | Cream | Topical | 2 g/100 g | 2023 | |
| |||||
Pacifica Beauty, LLC | Liquid | Topical | 2 g/100 mL | 2023 | |
| |||||
Pacifica Beauty, LLC | Liquid | Topical | 2 g/100 mL | 2023 | |
| |||||
Harmon Stores Inc. | Liquid | Topical | 20 mg/1 mL | 2016 | |
Indications
| |||||
Harmon Stores Inc. | Liquid | Topical | 20 mg/1 mL | 2010 | |
Indications
| |||||
Old East Main Co. | Lotion | Topical | 20 mg/1 mL | 2008 | |
Indications
| |||||
Target Corporation | Liquid | Topical | 1 mg/100 mg | 2024 | |
Indications
| |||||
Rejoice International Corp | Liquid | Topical | 2 g/200 mL | 2016 | |
Indications
| |||||
Rejoice International Corp. | Liquid | Topical | 2 g/200 mL | 2016 | |
Indications
| |||||
RAPHAS CO. , LTD | Patch | Topical | 0.012 mg/0.6013 mg | 2024 | |
| |||||
Allure Labs | Cream | Topical | 2 g/100 g | 2026 | |
Indications
| |||||
Guangzhou ChuanMa International Trading Co. , Ltd. | Liquid | Topical | 8 g/100 mL | 2025 | |
| |||||
Dermalogica, Inc | Liquid | Topical | 20 mg/1 mL | 2019 | |
Indications
| |||||
NSE Products, Inc | Lotion | Topical | 5 mg/1 mL | 2017 | |
Indications
| |||||
Banuskin, Inc. | Liquid | Topical | 2 g/100 mL | 2025 | |
Indications
| |||||
Skinkure | Liquid | Topical | 2 g/100 mL | 2023 | |
Indications
| |||||
SKIN PS Brands | Swab | Topical | 2 g/100 mL | 2023 | |
Indications
| |||||
Shenzhen Yikai Electronic Technology Co. , Ltd. | Liquid | Topical | 12 g/100 mL | 2023 | |
Indications
| |||||
The Hain Celestial Group, Inc. | Lotion | Topical | 2 g/100 g | 2017 | |
Indications
| |||||
The Hain Celestial Group, Inc. | Cream | Topical | 2 g/100 g | 2017 | |
Indications
| |||||
Blaine Labs Inc. | Gel | Topical | 0.5 g/100 g | 2022 | |
Indications
| |||||
ALMAY | Liquid | Topical | 2 mg/2 mL | 2021 | |
Indications
| |||||
ALMAY | Liquid | Topical | 2 mg/2 mL | 2021 | |
Indications
| |||||
ALMAY | Liquid | Topical | 2 mg/2 mL | 2021 | |
Indications
| |||||
ALMAY | Liquid | Topical | 2 mg/2 mL | 2021 | |
Indications
| |||||
ALMAY | Liquid | Topical | 2 mg/2 mL | 2021 | |
Indications
| |||||
ALMAY | Liquid | Topical | 2 mg/2 mL | 2021 | |
Indications
| |||||
Almay | Liquid | Topical | 2 mg/2 mL | 2018 | |
Indications
| |||||
Almay | Liquid | Topical | 2 mg/2 mL | 2018 | |
Indications
| |||||
Almay | Liquid | Topical | 2 mg/2 mL | 2018 | |
Indications
| |||||
Almay | Liquid | Topical | 2 mg/2 mL | 2018 | |
Indications
| |||||
Almay | Liquid | Topical | 2 mg/2 mL | 2018 | |
Indications
| |||||
Almay | Liquid | Topical | 2 mg/2 mL | 2018 | |
Indications
| |||||
Almay | Liquid | Topical | 2 mg/2 mL | 2018 | |
Indications
| |||||
ALMAY | Emulsion | Topical | 1 mg/1 mL | 2021 | |
Indications
| |||||
ALMAY | Emulsion | Topical | 1 mg/1 mL | 2021 | |
Indications
| |||||
ALMAY | Emulsion | Topical | 1 mg/1 mL | 2021 | |
Indications
| |||||
ALMAY | Emulsion | Topical | 1 mg/1 mL | 2021 | |
Indications
| |||||
ALMAY | Emulsion | Topical | 1 mg/1 mL | 2021 | |
Indications
| |||||
ALMAY | Emulsion | Topical | 1 mg/1 mL | 2021 | |
Indications
| |||||
ALMAY | Emulsion | Topical | 1 mg/1 mL | 2021 | |
Indications
| |||||
ALMAY | Emulsion | Topical | 1 mg/1 mL | 2021 | |
Indications
| |||||
ALMAY | Emulsion | Topical | 1 mg/1 mL | 2021 | |
Indications
| |||||
ALMAY | Emulsion | Topical | 1 mg/1 mL | 2021 | |
Indications
| |||||
ALMAY | Emulsion | Topical | 1 mg/1 mL | 2021 | |
Indications
| |||||
ALMAY | Emulsion | Topical | 1 mg/1 mL | 2021 | |
Indications
| |||||
ALMAY | Emulsion | Topical | 1 mg/1 mL | 2021 | |
Indications
| |||||
ALMAY | Emulsion | Topical | 1 mg/1 mL | 2021 | |
Indications
| |||||
ALMAY | Emulsion | Topical | 1 mg/1 mL | 2021 | |
Indications
| |||||
Alumier Labs | Cream | Topical | 20 mg/1 mL | 2019 | |
Indications
| |||||
Alumier Labs | Gel | Topical | 20 mg/1 mL | 2019 | |
Indications
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Liquid | Topical | 17 g/100 mL | 2026 | |
Indications
| |||||
AMAZON. COM SERVICES LLC | Lotion | Topical | 20 mg/1 g | 2023 | |
Indications
| |||||
AMAZON. COM SERVICES LLC | Liquid | Topical | 20 mg/1 mL | 2023 | |
Indications
| |||||
AMAZON. COM SERVICES LLC | Lotion | Topical | 20 mg/1 mL | 2023 | |
Indications
| |||||
AMBI ENTERPRISES, LLC | Gel | Topical | 15 mg/1 g | 2020 | |
Indications
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Liquid | Topical | 17 g/100 mL | 2026 | |
Indications
| |||||
June Jacobs Labs, LLC | Swab | Topical | 2.366 g/118.29 g | 2012 | |
Indications
| |||||
Bentley Laboratories, LLC | Lotion | Topical | 1.0 g/100 mL | 2024 | |
Indications
| |||||
Bentley laboratories, llC | Liquid | Topical | 2.0 g/100 mL | 2024 | |
Indications
| |||||
Guangzhou Zhicunxiu Cosmetics Co. , Ltd | Patch | Topical | 5 mg | 2024 | |
Indications
| |||||
Guangzhou Zhicunxiu Cosmetics Co. , Ltd | Patch | Topical | 5 mg | 2024 | |
Indications
| |||||
Guangzhou Zhicunxiu Cosmetics Co. , Ltd | Patch | Topical | 5 mg | 2024 | |
Indications
| |||||
Guangzhou Zhicunxiu Cosmetics Co. , Ltd | Patch | Topical | 20 mg | 2024 | |
Indications
| |||||
Guangzhou Zhicunxiu Cosmetics Co. , Ltd | Patch | Topical | 5 mg | 2024 | |
Indications
| |||||
SpineStatus LLC | Cream | Topical | 1 g/100 g | 2025 | |
Indications
| |||||
Access Business Group LLC | Gel | Topical | 20 mg/1 mL | 2021 | |
Indications
| |||||
Access Business Group LLC | Liquid | Topical | 10 mg/1 mL | 2020 | |
Indications
| |||||
Genomma Lab USA | Liquid | Topical | 18.6 mg/1 mL | 2024 | |
Indications
| |||||
Genomma Lab USA | Cream | Topical | 20 mg/1 g | 2024 | |
Indications
| |||||
Genomma Lab USA | Soap | Topical | 18 mg/1 g | 2025 | |
Indications
| |||||
Genomma Lab USA | Soap | Topical | 2 g/100 g | 2020 | |
Indications
| |||||
Genomma Lab USA | Soap | Topical | 2 g/100 g | 2020 | |
Indications
| |||||
Genomma Lab USA | Soap | Topical | 2 g/100 g | 2020 | |
Indications
| |||||
Genomma Lab USA | Soap | Topical | 2 g/100 g | 2020 | |
Indications
| |||||
Genomma Lab USA | Soap | Topical | 2 g/100 g | 2020 | |
Indications
| |||||
PureTek Corporation | Cream | Topical | 20 mg/1 mL | 2021 | |
Indications
| |||||
PURETEK CORPORATION | Liquid | Topical | 20 mg/1 mL | 2021 | |
Indications
| |||||
PureTek Corporation | Liquid | Topical | 20 mg/1 mL | 2021 | |
Indications
| |||||
Aveda Corporation | Solution | Topical | 15 mg/1 g | 2021 | |
Indications
| |||||
Kenvue Brands LLC | Lotion | Topical | 5 mg/1 mL | 2004 | |
Indications
| |||||
Kenvue Brands LLC | Liquid | Topical | 5 mg/1 mL | 2008 | |
Indications
| |||||
Kenvue Brands LLC | Lotion | Topical | 5 mg/1 mL | 2025 | |
Indications
| |||||
Kenvue Brands LLC | Lotion | Topical | 5 mg/1 mL | 2022 | |
Indications
| |||||
Kenvue Brands LLC | Liquid | Topical | 5 mg/1 mL | 2022 | |
Indications
| |||||
Pierre Fabre USA Inc. | Liquid | Topical | 2 mg/200 mL | 2023 | |
Indications
| |||||
Conopco Inc. d/b/a/ Unilever | Soap | Topical | 2 g/100 g | 2022 | |
Indications
| |||||
METHODIQ INC. | Gel | Topical | 5 mg/1 mL | 2025 | |
Indications
| |||||
Fourstar Group USA, Inc. | Cream | Topical | 5 mg/1 g | 2024 | |
Indications
| |||||
Fourstar Group USA, Inc. | Cream | Topical | 5 mg/1 g | 2024 | |
Indications
| |||||
Fourstar Group USA, Inc. | Powder | Topical | 5 mg/1 g | 2024 | |
Indications
| |||||
Fourstar Group USA, Inc. | Powder | Topical | 5 mg/1 g | 2024 | |
Indications
| |||||
Offspring Beauty Co. | Spray | Topical | 20 mg/1 mL | 2020 | |
Indications
| |||||
Brilliance Trade LLC | Liquid | Topical | 17 mg/1 mL | 2025 | |
Indications
| |||||
Orveon Global US LLC | Emulsion | Topical | 10 mg/1 g | 2016 | |
Indications
| |||||
Orveon Global US LLC | Powder | Topical | 30 mg/6 g | 2019 | |
Indications
| |||||
Mission Series Inc. dpa Prestige Beauty Care | Liquid | Topical | 0.05 g/100 mL | 2020 | |
Indications
| |||||
Mission Series Inc. dpa Prestige Beauty Care | Solution | Topical | 0.05 g/100 mL | 2023 | |
Indications
| |||||
Shenzhen Deshijian Medical Equipment Co. , Ltd | Cream | Topical | 5 g/100 mL | 2025 | |
| |||||
Shenzhen Earth Surface Trading Co. , Ltd. | Liquid | Topical | 12 g/100 mL | 2025 | |
Indications
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Liquid | Topical | 17 g/100 mL | 2026 | |
Indications
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Liquid | Topical | 1 g/100 mL | 2026 | |
Indications
| |||||
Skinfix, Inc. | Lotion | Topical | 2 g/100 mL | 2022 | |
Indications
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Cream | Topical | 17 g/100 g | 2026 | |
Indications
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Liquid | Topical | 17 g/100 mL | 2026 | |
Indications
| |||||
Murad, LLC | Solution | Topical | 1 g/100 mL | 2025 | |
Indications
| |||||
QUEST USA CORP | Plaster | Topical | 0.4 g/1 g | 2025 | |
Indications
| |||||
Zhejiang Dingtai Pharmaceutical Co. , Ltd | Plaster | Topical | 0.4 g/1 g | 2024 | |
Indications
| |||||
Kao USA Inc. | Liquid | Topical | 1 g/100 g | 2025 | |
Indications
| |||||
Kao USA Inc. | Liquid | Topical | 2.8 g/141 g | 2011 | |
Indications
| |||||
Kao USA Inc. | Liquid | Topical | 2 g/100 mL | 2018 | |
Indications
| |||||
Kao USA Inc. | Liquid | Topical | 4.3 g/200 mL | 2011 | |
Indications
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Liquid | Topical | 17 g/100 mL | 2026 | |
Indications
| |||||
Walmart Inc. | Gel | Topical | 20 mg/1 g | 2007 | |
Indications
| |||||
CLINIQUE LABORATORIES LLC | Cream | Topical | 10 mg/1 mL | 2018 | |
Indications
| |||||
CLINIQUE LABORATORIES LLC | Cream | Topical | 10 mg/1 mL | 2018 | |
Indications
| |||||
Guangdong Quadrant Ecological Technology Co. , Ltd. | Liquid | Topical | 0.17 g/1 mL | 2026 | |
Indications
| |||||
Equibal, Inc. | Lotion | Topical | 1500 mg/29000 mg | 2025 | |
Indications
| |||||
Equibal, Inc. | Lotion | Topical | 0.587 g/118 mL | 2025 | |
Indications
| |||||
Guangdong Joyan Biological Technology Co. , Ltd | Liquid | Topical | 0.01 g/1 mL | 2025 | |
Indications
| |||||
CP Skin Health Group, Inc. | Soap | Topical | 2 g/100 g | 2016 | |
Indications
| |||||
Ganzhou Olivee Cosmetic Co. , Ltd. | Patch | Topical | 0.5 g/100 g | 2024 | |
Indications
| |||||
Ganzhou Olivee Cosmetic Co. , Ltd. | Patch | Topical | 0.5 g/100 g | 2024 | |
Indications
| |||||
Topiderm, Inc. | Liquid | Topical | 109 mg/1 mL | 2022 | |
Indications
| |||||
Ganzhou Olivee Cosmetic Co. , Ltd. | Patch | Topical | 5 g/100 g | 2024 | |
Indications
| |||||
Ganzhou Olivee Cosmetic Co. , Ltd. | Patch | Topical | 0.5 g/100 g | 2024 | |
Indications
| |||||
Ganzhou Olivee Cosmetic Co. , Ltd. | Patch | Topical | 0.5 g/100 g | 2024 | |
Indications
| |||||
Ganzhou Olivee Cosmetic Co. , Ltd. | Patch | Topical | 0.5 g/100 g | 2024 | |
Indications
| |||||
Juice Beauty | Lotion | Topical | 0.75 g/100 mL | 2014 | |
Indications
| |||||
Skin Script, LLC | Cream | Topical | 0.01 g/1 g | 2024 | |
Indications
| |||||
Skin PS Brands | Spray | Topical | 20 mg/1 g | 2023 | |
Indications
| |||||
Amazon. com Services LLC | Gel | Topical | 20 mg/1 mL | 2018 | |
Indications
| |||||
Topco Associates LLC | Gel | Topical | 20 mg/1 mL | 2015 | |
Indications
| |||||
Walmart Inc. | Gel | Topical | 20 mg/1 mL | 2015 | |
Indications
| |||||
Dermalogica, Inc. | Liquid | Topical | 2 mg/100 mL | 2021 | |
Indications
| |||||
Dermalogica, LLC. | Liquid | Topical | 2 g/100 mL | 2025 | |
Indications
| |||||
Dermalogica | Liquid | Topical | 5 mg/1 mL | 2013 | |
Indications
| |||||
Bentley Laboratories, LLC | Gel | Topical | 0.4 g/20 g | 2013 | |
Indications
| |||||
BUBBLE BEAUTY | Emulsion | Topical | 20 mg/1 mL | 2025 | |
Indications
| |||||
BUBBLE BEAUTY | Emulsion | Topical | 18 mg/1 mL | 2023 | |
Indications
| |||||
BUBBLE BEAUTY | Emulsion | Topical | 20 mg/1 mL | 2023 | |
Indications
| |||||
Shenzhen TeLaFaErJiaLuo Technology Co. , Ltd. | Liquid | Topical | 17 g/100 mL | 2025 | |
Indications
| |||||
Teamtrade Inc. | Cream | Topical | 2 g/100 mL | 2022 | |
Indications
| |||||
Byoma Ltd | Liquid | Topical | 20 mg/1 mL | 2025 | |
Indications
| |||||
Byoma Ltd | Liquid | Topical | 20 mg/1 mL | 2025 | |
Indications
| |||||
Byoma Ltd | Lotion | Topical | 20 mg/1 mL | 2025 | |
Indications
| |||||
Byoma Ltd | Lotion | Topical | 15 mg/1 mL | 2025 | |
Indications
| |||||
Byoma Ltd | Paste | Topical | 20 mg/1 mL | 2025 | |
Indications
| |||||
Shenzhen Jindali Technology Co. , Ltd | Liquid | Topical | 1 g/100 mL | 2026 | |
Indications
| |||||
Shenzhen Jindali Technology Co. , Ltd | Patch | Topical | 1 g/100 1 | 2026 | |
Indications
| |||||
Shenzhen Jindali Technology Co. , Ltd | Liquid | Topical | 17 g/100 mL | 2026 | |
Indications
| |||||
FSA Store Inc. (Caring Mills) | Liquid | Topical | 0.5 g/100 mL | 2025 | |
| |||||
Caudalie USA Inc. | Gel | Topical | 0.15 g/30 mL | 2025 | |
Indications
| |||||
Guangzhou Meijiao Medical Biotechnology Co. , Ltd. | Cream | Transdermal | 1 g/15 mL | 2025 | |
| |||||
Guangzhou Meijiao Medical Biotechnology Co. , Ltd. | Cream | Transdermal | 1 g/15 g | 2025 | |
| |||||
L’Oreal USA Products Inc | Gel | Topical | 20 mg/1 mL | 2025 | |
Indications
| |||||
L'Oreal USA Products Inc | Gel | Topical | 20 mg/1 mL | 2021 | |
Indications
| |||||
L'Oreal USA Products Inc | Gel | Topical | 20 mg/1 mL | 2021 | |
Indications
| |||||
Unette Corporation | Gel | Topical | 20 mg/1 mL | 2021 | |
Indications
| |||||
L'Oreal USA Products Inc | Gel | Topical | 20 mg/1 mL | 2023 | |
Indications
| |||||
Galderma Laboratories, L. P. | Gel | Topical | 20 mg/1 mL | 2022 | |
Indications
| |||||
Galderma Laboratories, L. P. | Cream | Topical | 20 mg/1 mL | 2021 | |
Indications
| |||||
Galderma Laboratories, L. P. | Lotion | Topical | 5 mg/1 mL | 2021 | |
Indications
| |||||
Galderma Laboratories, L. P. | Gel | Topical | 20 mg/1 mL | 2024 | |
Indications
| |||||
Galderma Laboratories, L. P. | Solution | Topical | 5 mg/1 mL | 2022 | |
Indications
| |||||
VIREO SYSTEMS, INC. | Cream | Topical | 5 mg/1 mL | 2022 | |
Indications
| |||||
Dermalogica, LLC. | Spray | Topical | 1 g/100 mL | 2023 | |
Indications
| |||||
Murad, LLC | Solution | Topical | 0.5 g/100 mL | 2025 | |
Indications
| |||||
Murad, LLC | Solution | Topical | 1.5 g/100 mL | 2025 | |
Indications
| |||||
Skin Authority LLC | Gel | Topical | 2 g/100 mL | 2012 | |
Indications
| |||||
Allure Labs | Liquid | Topical | 1 g/100 g | 2023 | |
Indications
| |||||
Drmtlgy, LLC | Liquid | Topical | 2 g/100 mL | 2025 | |
Indications
| |||||
Kenvue Brands LLC | Liquid | Topical | 20 mg/1 mL | 2023 | |
Indications
| |||||
Kenvue Brands LLC | Gel | Topical | 20 mg/1 mL | 2023 | |
Indications
| |||||
Kenvue Brands LLC | Gel | Topical | 20 mg/1 g | 2016 | |
Indications
| |||||
Kenvue Brands LLC | Lotion | Topical | 20 mg/1 mL | 2006 | |
Indications
| |||||
Kenvue Brands LLC | Cream | Topical | 20 mg/1 g | 2016 | |
Indications
| |||||
Kenvue Brands LLC | Liquid | Topical | 20 mg/1 mL | 2023 | |
Indications
| |||||
Kenvue Brands LLC | Liquid | Topical | 20 mg/1 mL | 2012 | |
Indications
| |||||
Kenvue Brands LLC | Lotion | Topical | 5 mg/1 mL | 2023 | |
Indications
| |||||
Cosmetic Enterprises Ltd | Spray | Topical | 2 g/118 mL | 2016 | |
| |||||
Kamedis | Liquid | Topical | 14.4 mg/1 mL | 2018 | |
Indications
| |||||
Kamedis | Lotion | Topical | 28.8 mg/1 mL | 2018 | |
Indications
| |||||
Kamedis | Liquid | Topical | 28.8 mg/1 mL | 2018 | |
Indications
| |||||
Scholls Wellness Company LLC | Disc | Topical | 0.4 g/1 g | 2019 | |
Indications
| |||||
MEIJER DISTRIBUTION, INC. | Patch | Topical | 40 mg/12 1 | 2023 | |
Indications
| |||||
Philosophy | Gel | Topical | 0.3 g/15 mL | 2012 | |
Indications
| |||||
Philosophy Inc. | Cloth | Topical | 283.5 mg/56.7 g | 2012 | |
Indications
| |||||
Philosophy Inc. | Cream | Topical | 0.6 g/60 mL | 2012 | |
Indications
| |||||
Philosophy Inc. | Liquid | Topical | 2.4 g/240 mL | 2012 | |
Indications
| |||||
Cosmetic Enterprises Ltd | Cream | Topical | 2 g/100 mL | 2016 | |
| |||||
Arbonne International, LLC | Cloth | Topical | 0.5 mg/90 mL | 2015 | |
Indications
| |||||
Arbonne International, LLC | Gel | Topical | 0.5 mg/118 mL | 2015 | |
Indications
| |||||
Arbonne International, LLC | Lotion | Topical | 2 mg/15 mL | 2015 | |
Indications
| |||||
Chain Drug Consortium, LLC | Patch | Topical | 40 mg/6 1 | 2018 | |
Indications
| |||||
ORIGINS NATURAL RESOURCES INC. | Lotion | Topical | 15 mg/1 mL | 2024 | |
Indications
| |||||
ORIGINS NATURAL RESOURCES INC. | Liquid | Topical | 10 mg/1 mL | 2024 | |
Indications
| |||||
Mary Kay Inc. | Liquid | Topical | 2 g/100 mL | 2013 | |
Indications
| |||||
Mary Kay Inc. | Gel | Topical | 2 g/100 g | 2013 | |
Indications
| |||||
Renu Laboratories, Inc. | Gel | Topical | 1.04 g/52 mL | 2023 | |
| |||||
Distribuidora Comercial Jafra, S. A. de C. V | Gel | Topical | 1 g/100 mL | 2020 | |
Indications
| |||||
Distribuidora Comercial Jafra, S. A. de C. V. | Cream | Topical | 0.5 g/100 mL | 2022 | |
Indications
| |||||
Distribuidora Comercial Jafra, S. A. de C. V. | Liquid | Topical | 0.5 g/100 mL | 2020 | |
Indications
| |||||
Distribuidora Comercial Jafra, S. A. de C. V. | Liquid | Topical | 0.5 g/100 mL | 2020 | |
Indications
| |||||
Distribuidora Comercial Jafra, S. A. de C. V. | Gel | Topical | 0.5 g/100 mL | 2022 | |
Indications
| |||||
Bentley Laboratories, LLC | Gel | Topical | 2.0 g/100 mL | 2024 | |
Indications
| |||||
MEIJER DISTRIBUTION, INC. | Patch | Topical | 40 mg/12 1 | 2023 | |
Indications
| |||||
RB Health (US) LLC | Cloth | Topical | 0.02 g | 2017 | |
Indications
| |||||
RB Health (US) LLC | Lotion | Topical | 2 g/100 mL | 2017 | |
Indications
| |||||
RB Health (US) LLC | Cloth | Topical | 0.03 g | 2017 | |
Indications
| |||||
RB Health (US) LLC | Lotion | Topical | 2 g/100 mL | 2017 | |
Indications
| |||||
Ren Ltd. | Gel | Topical | 5 mg/1 mL | 2019 | |
Indications
| |||||
Dermalogica, LLC. | Liquid | Topical | 0.501 mg/100 mL | 2024 | |
Indications
| |||||
Mary Kay Inc. | Cream | Topical | 2 g/100 g | 2017 | |
Indications
| |||||
Mary Kay Inc. | Cream | Topical | 2 g/100 g | 2017 | |
Indications
| |||||
SRL ENTERPRISES LLC | Liquid | Topical | 0.25 g/50 mL | 2017 | |
Indications
| |||||
SRL Enterprises, LLC | Cloth | Topical | 5 mg/1 mL | 2020 | |
Indications
| |||||
Obagi Cosmeceuticals LLC | Liquid | Topical | 20 mg/1 mL | 2007 | |
Indications
| |||||
Obagi Cosmeceuticals LLC | Liquid | Topical | 20 mg/1 mL | 2007 | |
Indications
| |||||
CLINIQUE LABORATORIES LLC | Liquid | Topical | 15 mg/1 mL | 2024 | |
Indications
| |||||
TopMD Skin Care, Inc. | Liquid | Topical | 5 mg/1 mL | 2016 | |
Indications
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Liquid | Topical | 17 g/100 mL | 2026 | |
Indications
| |||||
Onekind.25 | Liquid | Topical | 1.5 g/100 mL | 2022 | |
Indications
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Liquid | Topical | 17 g/100 mL | 2026 | |
Indications
| |||||
ASO LLC | Gel | Topical | 170 mg/1 g | 2020 | |
Indications
| |||||
Medtech Products Inc. | Liquid | Topical | 150 mg/1 mL | 2014 | |
Indications
| |||||
Medtech Products Inc. | Gel | Topical | 170 mg/1 g | 2014 | |
Indications
| |||||
Medtech Products Inc. | Plaster | Topical | 4 mg | 2014 | |
Indications
| |||||
Medtech Products Inc. | Liquid | Topical | 0.17 g/9 g | 2014 | |
Indications
| |||||
Medtech Products Inc. | Plaster | Topical | 0.4 g | 2025 | |
Indications
| |||||
Medtech Products Inc. | Plaster | Topical | 0.4 g/1 g | 2025 | |
Indications
| |||||
Medtech Products Inc. | Plaster | Topical | 0.4 g | 2018 | |
Indications
| |||||
Medtech Products Inc. | Plaster | Topical | 0.4 g | 2025 | |
Indications
| |||||
Medtech Products Inc. | Plaster | Topical | 0.4 g | 2014 | |
Indications
| |||||
Medtech Products Inc. | Plaster | Topical | 0.4 g | 2014 | |
Indications
| |||||
Shenzhen Furuizhilian keji Co. , Ltd. | Patch | Topical | 9 g/60 g | 2024 | |
Indications
| |||||
Shenzhen Rongxing Trading Co. , Ltd. | Patch | Topical | 1 g/100 g | 2024 | |
| |||||
Shenzhen Rongxing Trading Co. , Ltd. | Patch | Topical | 1 g/100 g | 2024 | |
| |||||
Shenzhen Rongxing Trading Co. , Ltd. | Patch | Topical | 1 g/100 g | 2024 | |
| |||||
Shenzhen Rongxing Trading Co. , Ltd. | Patch | Topical | 1 g/100 g | 2024 | |
| |||||
Shenzhen Rongxing Trading Co. , Ltd. | Patch | Topical | 1 g/100 g | 2024 | |
| |||||
Shenzhen Rongxing Trading Co. , Ltd. | Patch | Topical | 1 g/100 g | 2024 | |
| |||||
Shenzhen Rongxing Trading Co. , Ltd. | Patch | Topical | 1 g/100 g | 2024 | |
| |||||
Shenzhen Yangan Technology Co. , Ltd. | Patch | Topical | 40 mg/100 mg | 2024 | |
| |||||
WinCo Foods LLC | Patch | Topical | 400 mg/1 g | 2024 | |
Indications
| |||||
Balassa Laboratories Inc. | Stick | Topical | 0.4 g/1 g | 1967 | |
Indications
| |||||
Oxygen Development LLC | Lotion | Topical | 1.5 mg/100 mg | 2023 | |
Indications
| |||||
Dime Beauty Co, LLC | Cream | Topical | 0.5 g/100 mL | 2022 | |
| |||||
Skin Pharm, LLC | Patch | Topical | 2 g/100 mL | 2023 | |
Indications
| |||||
Pharmaplast SAE | Patch | Topical | 40 mg | 2014 | |
Indications
| |||||
Curology, Inc. | Gel | Topical | 2 g/100 mL | 2025 | |
Indications
| |||||
CVS Health | Lotion | Topical | 20 mg/1 mL | 2014 | |
Indications
| |||||
CVS Health | Lotion | Topical | 20 mg/1 mL | 2014 | |
Indications
| |||||
CVS PHARMACY | Gel | Topical | 20 mg/1 mL | 2019 | |
Indications
| |||||
Bioelements, Inc. | Lotion | Topical | 20 mg/1 mL | 2024 | |
Indications
| |||||
METHODIQ INC. | Cream | Topical | 5 mg/1 mL | 2025 | |
Indications
| |||||
Guangzhou ChuanMa International Trading Co. , Ltd. | Cream | Topical | 17 g/100 g | 2026 | |
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Liquid | Topical | 17 g/100 mL | 2026 | |
Indications
| |||||
Meijer, Inc. | Liquid | Topical | 5 mg/1 mL | 2013 | |
Indications
| |||||
derma e | Paste | Topical | 20 mg/1 g | 2015 | |
Indications
| |||||
Defense Soap LLC | Soap | Topical | 2 g/100 g | 2019 | |
Indications
| |||||
Yantai Aien Biotechnology Co. , Ltd. | Gel | Topical | 0.5 g/100 g | 2026 | |
| |||||
BCM Cosmetique SAS | Lotion | Topical | 1 g/1 g | 2025 | |
Indications
| |||||
derma e | Liquid | Topical | 190 mg/1 mL | 2022 | |
Indications
| |||||
derma e | Cloth | Topical | 190 mg/1 mL | 2024 | |
Indications
| |||||
derma e | Lotion | Topical | 5.3 mg/1 g | 2021 | |
Indications
| |||||
Pella Pharmaceuticals Co. Ltd | Gel | Topical | 18 mg/1 g | 2023 | |
Indications
| |||||
Pella Pharmaceuticals Co. Ltd | Solution | Topical | 5 mg/1 mL | 2023 | |
Indications
| |||||
ZENMED Raging Creations Ltd. | Gel | Topical | 0.02 g/1 mL | 2023 | |
Indications
| |||||
ZENMED Raging Creations Ltd. | Gel | Topical | 0.02 g/1 mL | 2025 | |
Indications
| |||||
Allure Labs Inc | Lotion | Topical | 2 mg/1 mL | 2014 | |
Indications
| |||||
Allure Labs | Gel | Topical | 2 mg/1 g | 2020 | |
Indications
| |||||
Allure Labs Inc, | Cream | Topical | 20 mg/1 g | 2015 | |
Indications
| |||||
Allure Labs | Liquid | Topical | 20 mg/1 g | 2015 | |
Indications
| |||||
Allure Labs Inc | Cream | Topical | 20 mg/1 mL | 2014 | |
Indications
| |||||
Chen Cohen Industries Inc. | Cream | Topical | 20 mg/1 g | 2021 | |
Indications
| |||||
Spa de Soleil | Liquid | Topical | 1.15 mg/230 mL | 2022 | |
Indications
| |||||
Spa de Soleil | Liquid | Topical | 1.8 mg/180 mL | 2023 | |
Indications
| |||||
Spa de Soleil | Cream | Topical | 0.5 mg/50 mL | 2023 | |
Indications
| |||||
Spa de Soleil | Liquid | Topical | 1 mg/100 mL | 2023 | |
Indications
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Liquid | Topical | 17 g/100 mL | 2026 | |
Indications
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Liquid | Topical | 1 g/100 mL | 2026 | |
Indications
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Patch | Topical | 40 g/100 1 | 2026 | |
Indications
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | System | Topical | 17 g/100 mL | 2026 | |
Indications
| |||||
Jiangxi Hemei Pharmaceutical Co. , Ltd | Patch | Topical | 1 g/100 1 | 2025 | |
Indications
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Patch | Topical | 1 g/100 1 | 2026 | |
Indications
| |||||
COSMAX USA, CORPORATION | Liquid | Topical | 2 mg/100 mg | 2024 | |
Indications
| |||||
KENDO HOLDINGS INC. | Liquid | Topical | 2 g/100 mL | 2025 | |
Indications
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Cream | Topical | 17 g/100 g | 2026 | |
Indications
| |||||
Dickinson Brands Inc. | Liquid | Topical | 0.032 g/1.58 mL | 2025 | |
Indications
| |||||
Dickinson Brands Inc. | Liquid | Topical | 0.0039 g/1 mL | 2025 | |
Indications
| |||||
Galderma Laboratories, L. P. | Aerosol, Spray | Topical | 2 g/100 g | 2022 | |
Indications
| |||||
Galderma Laboratories, L. P. | Liquid | Topical | 20 mg/1 mL | 2021 | |
Indications
| |||||
Galderma Laboratories, L. P. | Gel | Topical | 20 mg/1 mL | 2022 | |
Indications
| |||||
Advaccine Biopharmaceuticals Suzhou Co. , Ltd | Patch | Topical | 5 mg/1000 mg | 2025 | |
Indications
| |||||
Advaccine Biopharmaceuticals Suzhou Co. , Ltd | Patch | Topical | 5 mg/1000 mg | 2025 | |
Indications
| |||||
Personal Day Inc. | Liquid | Topical | 20 mg/1 mL | 2024 | |
Indications
| |||||
Youngwon Costech Co. , ltd. | Patch | Topical | 0.005 g | 2023 | |
Indications
| |||||
CONOPCO Inc. d/b/a Unilever | Liquid | Topical | 1 g/100 mL | 2022 | |
Indications
| |||||
CONOPCO Inc. d/b/a Unilever | Liquid | Topical | 1 g/100 mL | 2023 | |
Indications
| |||||
Longway Lab Inc. | Stick | Topical | 0.02 g/1 mL | 2026 | |
Indications
| |||||
Longway Technology (Guangzhou) Co. , Ltd. | Stick | Topical | 0.02 g/1 g | 2026 | |
Indications
| |||||
Derma Care Research Labs, LLC | Liquid | Topical | 2 g/100 g | 2021 | |
| |||||
Derma Care Research Labs, LLC | Liquid | Topical | 2 g/100 g | 2021 | |
| |||||
Farmasi US LLC | Liquid | Topical | 10 mg/1 mL | 2021 | |
Indications
| |||||
Farmasi US LLC | Gel | Topical | 20 mg/1 mL | 2021 | |
Indications
| |||||
Farmasi US LLC | Liquid | Topical | 5 mg/1 mL | 2021 | |
Indications
| |||||
Topiderm, Inc | Gel | Topical | 20 mg/1 mL | 2023 | |
Indications
| |||||
GOWOONSESANG COSMETICS CO. , LTD. | Cream | Topical | 2 g/100 mL | 2024 | |
Indications
| |||||
GOWOONSESANG COSMETICS CO. , LTD. | Cream | Topical | 0.5 g/100 mL | 2024 | |
Indications
| |||||
GOWOONSESANG COSMETICS CO. , LTD. | Liquid | Topical | 0.5 g/100 mL | 2024 | |
Indications
| |||||
GOWOONSESANG COSMETICS CO. , LTD. | Liquid | Topical | 0.5 g/100 mL | 2024 | |
Indications
| |||||
Topiderm, Inc | Liquid | Topical | 20 mg/1 mL | 2023 | |
Indications
| |||||
Spa de Soleil | Liquid | Topical | 1.15 mg/230 mL | 2023 | |
Indications
| |||||
DANOUS LAND FLOOW LLC | Solution | Topical | 170 mg/1000 mL | 2025 | |
Indications
| |||||
Shandong Yuyaotang Pharmaceutical Co. , Ltd | Liquid | Topical | 17 g/100 mL | 2024 | |
Indications
| |||||
Longway Lab Inc. | Stick | Topical | 0.02 g/1 mL | 2026 | |
Indications
| |||||
Longway Technology (Guangzhou) Co. , Ltd. | Stick | Topical | 0.02 g/1 mL | 2026 | |
Indications
| |||||
Shenzhen Zealous Ecommerce Technology Co. , Ltd | Liquid | Topical | 5 g/100 mL | 2025 | |
Indications
| |||||
Topiderm, Inc. | Cloth | Topical | 20 mg | 2023 | |
Indications
| |||||
Guangzhou ChuanMa International Trading Co. , Ltd. | Liquid | Topical | 17 g/100 g | 2026 | |
Indications
| |||||
OL PHARMA TECH, LLC Drs. PHARMACY | Gel | Topical | 5 mg/1 g | 2022 | |
Indications
| |||||
OL PHARMA TECH, LLC Drs. PHARMACY | Gel | Topical | 20 mg/1 g | 2022 | |
Indications
| |||||
Pacifica Beauty, LLC | Gel | Topical | 2 g/100 mL | 2023 | |
| |||||
METHODIQ INC. | Gel | Topical | 20 mg/1 mL | 2025 | |
Indications
| |||||
Guangzhou Huixue Biotechnology Co. , Ltd. | Liquid | Topical | 6 mg/30 g | 2026 | |
Indications
| |||||
Zhejiang Ayan Biotech Co. , Ltd. | Liquid | Topical | 2 g/100 mL | 2024 | |
| |||||
e. l. f. Cosmetics, Inc | Liquid | Topical | 20 mg/1 mL | 2023 | |
Indications
| |||||
e. l. f. Cosmetics, Inc. | Liquid | Topical | 20 mg/1 mL | 2025 | |
Indications
| |||||
Shantou Eelhoe Daily Chemical Technology Co. , Ltd. | Patch | Topical | 0.02 g/100 g | 2024 | |
| |||||
Guangdong Eelhoe Biotechnology Co. , Ltd. | Patch | Topical | 2 g/100 g | 2024 | |
Indications
| |||||
Shantou South Moon Biotechnology Co. , Ltd. | Patch | Topical | 2 g/100 g | 2024 | |
| |||||
Shantou Ximonth Biotechnology Co. , Ltd. | Patch | Topical | 2 g/100 g | 2024 | |
| |||||
Vitamex USA, Corp | Solution | Topical | 170 mg/1 mL | 2024 | |
| |||||
Aramode | Liquid | Topical | 1 g/100 mL | 2024 | |
Indications
| |||||
Shenzhen Xinxin Yunhai Technology Co. , Ltd. | Liquid | Topical | 17 g/100 mL | 2025 | |
Indications
| |||||
Shenzhen Xinxin Yunhai Technology Co. , Ltd. | Cream | Topical | 17 g/100 g | 2026 | |
Indications
| |||||
Speer Laboratories, LLC | Liquid | Topical | 2 g/100 mL | 2015 | |
Indications
| |||||
Shaklee Corporation | Lotion | Topical | 5 mg/1 mL | 2013 | |
Indications
| |||||
Walmart INC | Cream | Topical | 20 mg/1 mL | 2025 | |
Indications
| |||||
Walmart, Inc. | Swab | Topical | 2 g/100 g | 2021 | |
Indications
| |||||
WALMART INC | Soap | Topical | 2000 mg/100 mL | 2022 | |
Indications
| |||||
WALMART INC. | Soap | Topical | 2000 mg/100 mL | 2022 | |
Indications
| |||||
WALMART INC. | Cream | Topical | 20 mg/1 g | 2025 | |
Indications
| |||||
Bath Concept Cosmetics (Dongguan) Co. , Ltd | Cloth | Topical | 20 mg/1 mL | 2021 | |
Indications
| |||||
Walmart Inc. | Plaster | Topical | 40 mg | 2023 | |
Indications
| |||||
Walmart Inc. | Patch | Topical | 40 mg/100 mg | 2023 | |
Indications
| |||||
KATE SOMERVILLE SKINCARE, LLC | Gel | Topical | 2 g/100 mL | 2021 | |
Indications
| |||||
Rare Beauty Brands Inc. | Gel | Topical | 2 g/100 mL | 2021 | |
Indications
| |||||
Ambi Enterprises LLC | Liquid | Topical | 5 mg/1 mL | 2014 | |
Indications
| |||||
Ambi Enterprises, LLC | Liquid | Topical | 15 mg/1 mL | 2026 | |
Indications
| |||||
CLINIQUE LABORATORIES LLC | Liquid | Topical | 5 mg/1 mL | 2023 | |
Indications
| |||||
Personal Day Inc. | Gel | Topical | 10.5 mg/1 mL | 2024 | |
Indications
| |||||
CONTROL CORRECTIVE SKINCARE INC | Solution | Topical | 2 g/100 mL | 2016 | |
Indications
| |||||
Wal-Mart Stores, Inc. | Patch | Topical | 40 mg/100 mg | 2013 | |
Indications
| |||||
NeoStrata Company Inc. | Liquid | Topical | 20 mg/1 mL | 2018 | |
Indications
| |||||
Shenzhen Shierjie Biological Engineering Co. , LTD | Cloth | Topical | 1 U/100 U | 2025 | |
Indications
| |||||
Shenzhen Yangan Technology Co. , Ltd. | Liquid | Topical | 1 mg/100 mL | 2025 | |
| |||||
Shenzhen Haizhida E-commerce Co. , Ltd | Ointment | Topical | 17 g/100 g | 2025 | |
Indications
| |||||
The Procter & Gamble Manufacturing Company | Disc | Topical | 2 g/100 mL | 2025 | |
Indications
| |||||
The Procter & Gamble Manufacturing Company | Spray | Topical | 2 g/100 mL | 2025 | |
Indications
| |||||
The Procter & Gamble Manufacturing Company | Gel | Topical | 2 g/100 mL | 2023 | |
Indications
| |||||
The Procter & Gamble Manufacturing Company | Disc | Topical | 2 g/100 mL | 2021 | |
Indications
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Liquid | Topical | 1 g/100 mL | 2026 | |
Indications
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Liquid | Topical | 17 g/100 mL | 2026 | |
Indications
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Cream | Topical | 17 g/100 g | 2026 | |
Indications
| |||||
Guangzhou Huixue Biotechnology Co. , Ltd. | Liquid | Topical | 6 mg/30 mL | 2026 | |
Indications
| |||||
Allure Labs | Liquid | Topical | 2 g/100 g | 2023 | |
Indications
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Liquid | Topical | 17 g/100 mL | 2026 | |
Indications
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Liquid | Topical | 1 g/100 mL | 2026 | |
Indications
| |||||
SANSAR, LLC | Cream | Topical | 12 g/100 g | 2025 | |
Indications
| |||||
Strategic Sourcing Services LLC | Plaster | Topical | 40 mg/100 mg | 2024 | |
Indications
| |||||
Guangdong Bawei Biotechnology Corporation | Emulsion | Topical | 5 mg/1 g | 2025 | |
Indications
| |||||
L'Oreal USA Products Inc | Gel | Topical | 20 mg/1 mL | 2014 | |
Indications
| |||||
Guangdong Quadrant Ecological Technology Co. , Ltd. | Liquid | Topical | 17 g/100 mL | 2025 | |
Indications
| |||||
Guangdong Quadrant Ecological Technology Co. , Ltd. | Liquid | Topical | 17 g/100 mL | 2025 | |
Indications
| |||||
Hengyang Chuangjiujia Trading Co. , Ltd. | Ointment | Topical | 0.4 g/1 g | 2024 | |
Indications
| |||||
Shanghai Yijing Medical Technology Co. , Ltd. | Cream | Topical | 2.6 g/100 g | 2025 | |
Indications
| |||||
Drmtlgy, LLC | Liquid | Topical | 2 g/100 g | 2025 | |
Indications
| |||||
Drmtlgy, LLC | Gel | Topical | 0.5 g/100 mL | 2025 | |
Indications
| |||||
Shenzhen Xituo Electronics Co. , Ltd | Liquid | Topical | 15 g/100 mL | 2025 | |
Indications
| |||||
Hayden Caleel LLC | Liquid | Topical | 2 g/100 g | 2017 | |
Indications
| |||||
Hayden Caleel LLC | Liquid | Topical | 1 g/100 g | 2025 | |
Indications
| |||||
Topiderm, Inc. | Cloth | Topical | 20 mg | 2019 | |
Indications
| |||||
Topiderm, Inc. | Liquid | Topical | 20 mg/1 mL | 2019 | |
Indications
| |||||
Topiderm, Inc. | Cloth | Topical | 0.02 g | 2000 | |
Indications
| |||||
Topiderm, Inc. | Cloth | Topical | 20 mg | 2019 | |
Indications
| |||||
Topiderm, Inc. | Liquid | Topical | 20 mg/1 mL | 2020 | |
Indications
| |||||
Topiderm, Inc. | Cloth | Topical | 0.02 g | 1990 | |
Indications
| |||||
Pierre Fabre USA | Liquid | Topical | 2 g/100 mL | 2017 | |
Indications
| |||||
Laboratoires Dermo-Cosmetik Inc. | Gel | Topical | 20 mg/1 mL | 2018 | |
Indications
| |||||
COSMAX USA, CORP | Gel | Topical | 2 mg/100 mL | 2025 | |
Indications
| |||||
Good Molecules | Gel | Topical | 2 g/100 mL | 2022 | |
Indications
| |||||
Good Molecules, LLC | Gel | Topical | 2 g/100 mL | 2024 | |
Indications
| |||||
Good Molecules, LLC | Gel | Topical | 2 g/100 mL | 2025 | |
Indications
| |||||
Twincraft Inc. | Gel | Topical | 2 g/100 mL | 2025 | |
Indications
| |||||
Twincraft Inc. | Gel | Topical | 2 g/100 mL | 2024 | |
Indications
| |||||
Good Molecules, LLC | Gel | Topical | 2 g/100 mL | 2025 | |
Indications
| |||||
Peter Thomas Roth, LLC | Gel | Topical | 0.9638 g/48.19 g | 2021 | |
Indications
| |||||
Zhengzhou Hangrui Network Technology Co. , Ltd. | Liquid | Topical | 17 g/100 mL | 2025 | |
Indications
| |||||
Zhengzhou Hangrui Network Technology Co. , Ltd. | Liquid | Topical | 1.5 g/100 mL | 2025 | |
Indications
| |||||
Zhengzhou Hangrui Network Technology Co. , Ltd. | Liquid | Topical | 0.17 g/1 mL | 2025 | |
Indications
| |||||
Zhengzhou Hangrui Network Technology Co. , Ltd. | Liquid | Topical | 17 g/100 mL | 2025 | |
Indications
| |||||
Zhengzhou Hangrui Network Technology Co. , Ltd. | Patch | Topical | 5 mg | 2025 | |
Indications
| |||||
Jiangxi Hemei Pharmaceutical Co. , Ltd | Cream | Topical | 17 g/100 g | 2025 | |
Indications
| |||||
Guangdong Aimu Biological Technology Co. , Ltd. | Cream | Topical | 1 g/120 g | 2024 | |
| |||||
H. E. B | Cream | Topical | 20 mg/1 mL | 2021 | |
Indications
| |||||
Maesa, LLC. | Liquid | Topical | 3 mg/118 mL | 2023 | |
Indications
| |||||
YITONGBADA (SHENZHEN) INTERNATIONAL TRADE CO. , LTD | Liquid | Topical | 18 g/100 mL | 2025 | |
Indications
| |||||
Ganzhou Olivee Cosmetic Co. , Ltd. | Patch | Topical | 0.5 g/100 g | 2024 | |
Indications
| |||||
Ganzhou Olivee Cosmetic Co. , Ltd. | Patch | Topical | 0.5 g/100 g | 2024 | |
Indications
| |||||
Ganzhou Olivee Cosmetic Co. , Ltd. | Patch | Topical | 0.5 g/100 g | 2024 | |
Indications
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Ointment | Topical | 17 g/100 g | 2026 | |
Indications
| |||||
Jiangxi Hemei Pharmaceutical Co. , Ltd | Liquid | Topical | 17 g/100 mL | 2025 | |
Indications
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Liquid | Topical | 17 g/100 mL | 2026 | |
Indications
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Patch | Topical | 40 g/100 1 | 2026 | |
Indications
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Liquid | Topical | 5 g/100 mL | 2026 | |
Indications
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Liquid | Topical | 17 g/100 mL | 2026 | |
Indications
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Liquid | Topical | 17 g/100 mL | 2026 | |
Indications
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Cream | Topical | 17 g/100 g | 2026 | |
Indications
| |||||
Kungpo Health Care & Herbal Center Inc | Gel | Topical | 2 g/100 g | 2025 | |
Indications
| |||||
Church & Dwight Co. , Inc. | Gel | Topical | 20 mg/1 mL | 2024 | |
Indications
| |||||
Church & Dwight Co. , Inc. | Liquid | Topical | 20 mg/1 mL | 2023 | |
Indications
| |||||
Memebox Corporation | Liquid | Topical | 1.5 g/100 mL | 2024 | |
Indications
| |||||
Shenzhen Earth Surface Trading Co. , Ltd. | Liquid | Topical | 12 g/100 mL | 2025 | |
Indications
| |||||
Shenzhen Hengkaifeng Commerce and Trade Co. , Ltd | Liquid | Topical | 12 g/100 mL | 2025 | |
Indications
| |||||
Shenzhen Hengkaifeng Commerce and Trade Co. , Ltd | Liquid | Topical | 12 g/100 mL | 2025 | |
Indications
| |||||
Shenzhen Hengkaifeng Commerce and Trade Co. , Ltd | Liquid | Topical | 12 g/100 mL | 2025 | |
Indications
| |||||
Swiss-American CDMO, LLC | Gel | Topical | 20 g/1000 g | 2025 | |
Indications
| |||||
The Honest Company, Inc | Liquid | Topical | 0.5 g/100 mL | 2022 | |
Indications
| |||||
Better Planet Brands LLC | Gel | Topical | 2 g/100 g | 2020 | |
Indications
| |||||
Innisfree Corporation | Gel | Topical | 1 g/50 mL | 2025 | |
Indications
| |||||
Shenzhen Xituo Electronics Co. , Ltd | Liquid | Topical | 15 g/100 mL | 2025 | |
Indications
| |||||
L'Oreal USA Products Inc | Lotion | Topical | 20 mg/1 mL | 2022 | |
Indications
| |||||
MAESA, LLC. | Spray | Topical | 2 mg/100 mL | 2022 | |
Indications
| |||||
Jack Black, L. L. C. | Liquid | Topical | 20 g/1000 g | 2020 | |
Indications
| |||||
Shantou Jaysuing Cleaning and Environmental Protection Technology Co. , Ltd. | Patch | Topical | 0.02 g/100 g | 2024 | |
| |||||
Guangzhou Huixue Biotechnology Co. , Ltd. | Liquid | Topical | 12 mg/30 mL | 2026 | |
Indications
| |||||
Guangzhou Yixiang Trading Co. , Ltd. | Swab | Topical | 1 g/100 g | 2025 | |
Indications
| |||||
Shanghai Zhulu Biotechnology Co. , Ltd | Liquid |
| 1.4 g/100 g | 2025 | |
Indications
| |||||
MANA PRODUCTS, INC. | Cream | Topical | 2 g/100 g | 2021 | |
Indications
| |||||
Offspring Beauty Co. / Versed | Rinse | Topical | 15 mg/1 mL | 2020 | |
Indications
| |||||
L'Oreal USA Products Inc | Paste | Topical | 20 mg/1 mL | 2025 | |
Indications
| |||||
L'Oreal USA Products Inc | Lotion | Topical | 15 mg/1 mL | 2017 | |
Indications
| |||||
L'Oreal USA Products Inc | Lotion | Topical | 15 mg/1 mL | 2016 | |
Indications
| |||||
L'Oreal USA Products Inc | Lotion | Topical | 15 mg/1 mL | 2016 | |
Indications
| |||||
L'Oreal USA Products Inc | Lotion | Topical | 12 mg/1 mL | 2023 | |
Indications
| |||||
L'Oreal USA Products Inc | Liquid | Topical | 20 mg/1 mL | 2023 | |
Indications
| |||||
Zitsticka, Inc. | Patch | Topical | 0.0125 mg/0.6216 mg | 2023 | |
Indications
| |||||
ZitSticka, Inc. | Patch | Topical | 0.0125 mg/0.6216 mg | 2023 | |
Indications
| |||||
ZitSticka, Inc. | Patch | Topical | 0.0125 mg/0.6216 mg | 2023 | |
| |||||
ZitSticka, Inc. | Patch | Topical | 0.0125 mg/0.6216 mg | 2023 | |
| |||||
Pharmadel | Liquid | Topical | 17 g/100 mL | 2024 | |
Indications
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Patch | Topical | 1 g/100 1 | 2026 | |
Indications
| |||||
THE KROGER COMPANY | Liquid | Topical | 20 mg/1 mL | 2017 | |
Indications
| |||||
L'BRI HEALTH AND BEAUTY INC | Liquid | Topical | 20 mg/1 mL | 2021 | |
Indications
| |||||
L'Oreal USA Products Inc | Gel | Topical | 20 mg/1 mL | 2022 | |
Indications
| |||||
COSMETIQUE ACTIVE PRODUCTION | Liquid | Topical | 15 mg/1 mL | 2022 | |
Indications
| |||||
COSMETIQUE ACTIVE PRODUCTION | Cream | Topical | 12 mg/1 mL | 2025 | |
Indications
| |||||
L'Oreal USA Products Inc | Cream | Topical | 12 mg/1 mL | 2025 | |
Indications
| |||||
L'Oreal USA Products Inc | Solution | Topical | 5 mg/1 mL | 2014 | |
Indications
| |||||
COSMETIQUE ACTIVE PRODUCTION | Liquid | Topical | 5 mg/1 mL | 2025 | |
Indications
| |||||
L'Oreal USA Products Inc | Liquid | Topical | 5 mg/1 mL | 2025 | |
Indications
| |||||
L'Oreal USA Products Inc | Liquid | Topical | 15 mg/1 mL | 2022 | |
Indications
| |||||
L'Oreal USA Products Inc | Gel | Topical | 20 mg/1 mL | 2014 | |
Indications
| |||||
Noon Aesthetics M. R. Ltd | Cream | Topical | 200 mg/1 mL | 2024 | |
Indications
| |||||
Ganzhou Olivee Cosmetic Co. , Ltd. | Patch | Topical | 5 mg/1 g | 2024 | |
Indications
| |||||
L’Oreal USA Products Inc | Liquid | Topical | 20 mg/1 mL | 2026 | |
Indications
| |||||
SICOS ET CIE | Liquid | Topical | 20 mg/1 mL | 2026 | |
Indications
| |||||
SANSAR, LLC | Gel | Topical | 12 g/100 mL | 2025 | |
Indications
| |||||
L'BRI Health & Beauty | Lotion | Topical | 20 mg/1 mL | 2024 | |
Indications
| |||||
GUNILLA OF SWEDEN, INC. | Gel | Topical | 20 mg/1 mL | 2024 | |
Indications
| |||||
Oxygen Development LLC | Liquid | Topical | 2 mg/100 mg | 2023 | |
Indications
| |||||
Premier Brands of America Inc. | Liquid | Topical | 170 mg/1 mL | 2023 | |
Indications
| |||||
Meijer Distribution Inc | Liquid | Topical | 170 mg/1 mL | 2015 | |
Indications
| |||||
Meijer Distribution Inc | Liquid | Topical | 170 mg/1 mL | 2023 | |
Indications
| |||||
Premier Brands of America, Inc. | Liquid | Topical | 0.17 g/9 mL | 2022 | |
Indications
| |||||
WinCo Foods LLC | Liquid | Topical | 170 mg/1 mL | 2024 | |
Indications
| |||||
Youngwon Costech Co. , ltd. | Patch | Topical | 0.005 g | 2022 | |
Indications
| |||||
XF Agencija Limited | Cream | Topical | 12 g/100 g | 2025 | |
Indications
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Patch | Topical | 17 g/100 1 | 2026 | |
Indications
| |||||
Remeverse | Cream | Topical | 0.225 g/15 g | 2020 | |
Indications
| |||||
PETER THOMAS ROTH LABS LLC | Liquid | Topical | 2 g/100 mL | 2025 | |
Indications
| |||||
Walmart | Liquid | Topical | 2 g | 2024 | |
Indications
| |||||
Shenzhen Yangan Technology Co. , Ltd. | Liquid | Topical | 5 mg/100 mL | 2024 | |
Indications
| |||||
Henan Toudaorong Biotechnology Co. , Ltd. | Patch | Topical | 30 mg/100 mg | 2025 | |
Indications
| |||||
Wal-Mart Stores, Inc. | Liquid | Topical | 17 mg/100 mg | 2011 | |
Indications
| |||||
L'Oreal USA Products Inc | Lotion | Topical | 20 mg/1 mL | 2014 | |
Indications
| |||||
MDAlgorithms Inc | Cream | Topical | 5 mg/1 mL | 2024 | |
Indications
| |||||
MDAlgorithms Inc | Cream | Topical | 20 mg/1 mL | 2024 | |
Indications
| |||||
Meijer, Inc. | Gel | Topical | 20 mg/1 g | 2008 | |
Indications
| |||||
Publix Super Markets, Inc. | Gel | Topical | 20 mg/1 g | 2008 | |
Indications
| |||||
Retail Business Services, LLC | Gel | Topical | 20 mg/1 g | 2010 | |
Indications
| |||||
Rite Aid Corporation | Gel | Topical | 19.8 mg/1 g | 2011 | |
Indications
| |||||
Topco Associates LLC | Gel | Topical | 20 mg/1 g | 2009 | |
Indications
| |||||
United Natural Foods, Inc. dba UNFI | Gel | Topical | 20 mg/1 g | 2015 | |
Indications
| |||||
Walmart Inc. | Gel | Topical | 20 mg/1 g | 2005 | |
Indications
| |||||
Meijer Distribution Inc. | Patch | Topical | 400 mg/1 g | 2023 | |
Indications
| |||||
Meijer Distribution Inc. | Patch | Topical | 40 mg/4 1 | 2023 | |
Indications
| |||||
Meijer Distribution Inc | Patch | Topical | 400 mg/1 g | 2017 | |
Indications
| |||||
Dolgencorp, Inc. (Dollar General & Rexall) | Patch | Topical | 40 mg/9 1 | 2015 | |
Indications
| |||||
Family Dollar Services, Inc | Patch | Topical | 400 mg/1 g | 2024 | |
Indications
| |||||
Meijer Distribution Inc | Patch | Topical | 400 mg/1 g | 2023 | |
Indications
| |||||
Meijer Distribution Inc | Patch | Topical | 400 mg/1 g | 2023 | |
Indications
| |||||
CARDINAL HEALTH 110, LLC. DBA LEADER | Plaster | Topical | 400 mg/1 g | 2025 | |
Indications
| |||||
Vivier Pharma, Inc. | Liquid | Topical | 20 mg/1 mL | 2017 | |
Indications
| |||||
Medline Industries, LP | Plaster | Topical | 40 g/100 g | 2008 | |
Indications
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Liquid | Topical | 17 g/100 mL | 2026 | |
Indications
| |||||
MEIJER DISTRIBUTION, INC | Lotion | Topical | 20 mg/1 mL | 2014 | |
Indications
| |||||
Meijer Distribution, Inc | Cream | Topical | 20 mg/1 g | 2011 | |
Indications
| |||||
Meijer Distribution, Inc | Lotion | Topical | 20 mg/1 mL | 2011 | |
Indications
| |||||
Meijer Distribution, Inc | Lotion | Topical | 5 mg/1 mL | 2011 | |
Indications
| |||||
Meijer Distribution, Inc | Lotion | Topical | 20 mg/1 mL | 2011 | |
Indications
| |||||
Shenzhen Xinxin Yunhai Technology Co. , Ltd. | Liquid | Topical | 10 g/100 mL | 2025 | |
Indications
| |||||
Shenzhen Xinxin Yunhai Technology Co. , Ltd. | Liquid | Topical | 1.5 g/100 mL | 2024 | |
Indications
| |||||
Shenzhen Xinxin Yunhai Technology Co. , Ltd. | Ointment | Topical | 1.5 g/100 g | 2024 | |
Indications
| |||||
Shenzhen Xinxin Yunhai Technology Co. , Ltd. | Patch | Topical | 40 g/100 1 | 2025 | |
Indications
| |||||
Dr. Loretta, LLC | Liquid | Topical | 20 mg/1 mL | 2019 | |
Indications
| |||||
Cosmax Usa, Corporation | Gel | Topical | 20 mg/1 mL | 2023 | |
Indications
| |||||
New Milani Group, LLC | Cream | Topical | 20 mg/1 mL | 2022 | |
Indications
| |||||
IHerb, LLC | Liquid | Topical | 20 mg/1 mL | 2025 | |
| |||||
Guangxi Keyun E-commerce Co. , Ltd. | Liquid | Topical | 0.01 g/1 mL | 2026 | |
Indications
| |||||
Cosmax Usa, Corporation | Lotion | Topical | 20 mg/1 mL | 2023 | |
Indications
| |||||
Zhengzhou Miaoqi Pharmaceutical Technology Co. , Ltd | Patch | Topical | 40 g/100 1 | 2023 | |
Indications
| |||||
Zhengzhou Miaoqi Pharmaceutical Technology Co. , Ltd | Liquid | Topical | 20 g/100 mL | 2023 | |
Indications
| |||||
StriVectin Operating Company, Inc. | Lotion | Topical | 2 g/100 mL | 2023 | |
Indications
| |||||
Shanghai Honghui Chuang Intelligent Technology Co. , Ltd | Patch | Topical | 1 g/100 1 | 2026 | |
Indications
| |||||
Ganzhou Olivee Cosmetic Co. , Ltd. | Patch | Topical | 0.5 g/100 g | 2024 | |
Indications
| |||||
Ganzhou Olivee Cosmetic Co. , Ltd. | Patch | Topical | 0.5 g/100 g | 2024 | |
Indications
| |||||
Ganzhou Olivee Cosmetic Co. , Ltd. | Patch | Topical | 0.5 g/100 g | 2024 | |
Indications
| |||||
Ganzhou Olivee Cosmetic Co. , Ltd. | Patch | Topical | 0.5 g/100 g | 2025 | |
Indications
| |||||
MELON BIO-TECH (THAILAND) CO. , LTD. | Patch | Topical | 0.5 g/100 g | 2025 | |
Indications
| |||||
Zhengzhou Miaoqi Pharmaceutical Technology Co. , Ltd | Patch | Topical | 40 g/100 1 | 2023 | |
Indications
| |||||
ALLI LLC | Gel | Topical | 10 mg/1 mL | 2025 | |
Indications
| |||||
ALLI LLC | Gel | Topical | 10 mg/1 mL | 2025 | |
Indications
| |||||
BURT'S BEES, INC. | Emulsion | Topical | 1 g/100 g | 2021 | |
Indications
| |||||
Burt's Bees | Liquid | Topical | 0.75 g/100 g | 2021 | |
Indications
| |||||
BURT'S BEES, INC. | Liquid | Topical | 1 g/100 1 | 2021 | |
Indications
| |||||
CDE BRANDS LLC | Liquid | Topical | 20 mg/1 mL | 2024 | |
Indications
| |||||
Natouch LLC | Soap | Topical | 1.2 g/120 g | 2020 | |
Indications
| |||||
Natouch LLC | Soap | Topical | 1.2 g/120 g | 2020 | |
Indications
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Cream | Topical | 17 g/100 g | 2026 | |
Indications
| |||||
Guangzhou Guocui Biotechnology Co. , Ltd | Poultice | Extracorporeal | 2 g/20 g | 2024 | |
Indications
| |||||
e. l. f. Cosmetics, Inc | Lotion | Topical | 7.5 mg/1 g | 2022 | |
Indications
| |||||
e. l. f. Cosmetics, Inc | Aerosol, Spray | Topical | 20 mg/1 mL | 2022 | |
Indications
| |||||
e. l. f. Cosmetics, Inc | Liquid | Topical | 20 mg/1 mL | 2022 | |
Indications
| |||||
Naturopathica Holistic Health | Gel | Topical | 2 g/100 mL | 2020 | |
Indications
| |||||
Naturopathica Holistic Health | Gel | Topical | 2 g/100 mL | 2020 | |
Indications
| |||||
Guoyu Trading Co. , Ltd. | Liquid | Topical | 5 g/100 mL | 2024 | |
Indications
| |||||
Guoyu Trading Co. , Ltd. | Patch | Topical | 1 g/100 1 | 2024 | |
Indications
| |||||
Neora, LLC | Swab | Topical | 0.5 g/100 mL | 2019 | |
Indications
| |||||
Kantian Skincare, LLC | Gel | Topical | 20 mg/1 mL | 2020 | |
Indications
| |||||
Kenvue Brands LLC | Liquid | Topical | 5 mg/1 g | 2017 | |
Indications
| |||||
Kenvue Brands LLC | Liquid | Topical | 20 mg/1 mL | 2016 | |
Indications
| |||||
Kenvue Brands LLC | Suspension | Topical | 20 mg/1 mL | 2020 | |
Indications
| |||||
Kenvue Brands LLC | Liquid | Topical | 20 mg/1 mL | 2020 | |
Indications
| |||||
Kenvue Brands LLC | Suspension | Topical | 20 mg/1 mL | 2020 | |
Indications
| |||||
Kenvue Brands LLC | Liquid | Topical | 20 mg/1 mL | 2025 | |
Indications
| |||||
Kenvue Brands LLC | Liquid | Topical | 20 mg/1 mL | 2020 | |
Indications
| |||||
Kenvue Brands LLC | Gel | Topical | 5 mg/1 g | 2017 | |
Indications
| |||||
Kenvue Brands LLC | Liquid | Topical | 20 mg/1 mL | 2025 | |
Indications
| |||||
Kenvue Brands LLC | Lotion | Topical | 5 mg/1 mL | 2025 | |
Indications
| |||||
Kenvue Brands LLC | Emulsion | Topical | 5 mg/1 g | 2025 | |
Indications
| |||||
Kenvue Brands LLC | Lotion | Topical | 5 mg/1 mL | 2019 | |
Indications
| |||||
Kenvue Brands LLC | Gel | Topical | 20 mg/1 mL | 2016 | |
Indications
| |||||
Kenvue Brands LLC | Liquid | Topical | 20 mg/1 mL | 2025 | |
Indications
| |||||
Kenvue Brands LLC | Liquid | Topical | 20 mg/1 mL | 2019 | |
Indications
| |||||
Kenvue Brands LLC | Lotion | Topical | 20 mg/1 mL | 2009 | |
Indications
| |||||
Kenvue Brands LLC | Liquid | Topical | 20 mg/1 mL | 2020 | |
Indications
| |||||
Kenvue Brands LLC | Liquid | Topical | 20 mg/1 mL | 2022 | |
Indications
| |||||
Kenvue Brands LLC | Cream | Topical | 20 mg/1 mL | 2011 | |
Indications
| |||||
Kenvue Brands LLC | Liquid | Topical | 20 mg/1 mL | 2020 | |
Indications
| |||||
Kenvue Brands LLC | Liquid | Topical | 20 mg/1 mL | 2025 | |
Indications
| |||||
Kenvue Brands LLC | Gel | Topical | 20 mg/1 mL | 2019 | |
Indications
| |||||
Kenvue Brands LLC | Liquid | Topical | 20 mg/1 mL | 2025 | |
Indications
| |||||
Kenvue Brands LLC | Cream | Topical | 20 mg/1 g | 2025 | |
Indications
| |||||
Kenvue Brands LLC | Cream | Topical | 20 mg/1 mL | 2019 | |
Indications
| |||||
Kenvue Brands LLC | Cream | Topical | 20 mg/1 g | 2025 | |
Indications
| |||||
Kenvue Brands LLC | Gel | Topical | 20 mg/1 mL | 2016 | |
Indications
| |||||
Kenvue Brands LLC | Liquid | Topical | 20 mg/1 mL | 2025 | |
Indications
| |||||
Kenvue Brands LLC | Gel | Topical | 20 mg/1 mL | 2016 | |
Indications
| |||||
Kenvue Brands LLC | Liquid | Topical | 20 mg/1 mL | 2024 | |
Indications
| |||||
Kenvue Brands LLC | Gel | Topical | 20 mg/1 mL | 2023 | |
Indications
| |||||
Kenvue Brands LLC | Gel | Topical | 20 mg/1 mL | 2019 | |
Indications
| |||||
Kenvue Brands LLC | Cloth | Topical | 20 mg | 2022 | |
Indications
| |||||
Kenvue Brands LLC | Cream | Topical | 5 mg/1 g | 2023 | |
Indications
| |||||
Kenvue Brands LLC | Powder | Topical | 5 mg/1 g | 2024 | |
Indications
| |||||
Kenvue Brands LLC | Liquid | Topical | 5 mg/1 mL | 2024 | |
Indications
| |||||
Kenvue Brands LLC | Lotion | Topical | 5 mg/1 mL | 2021 | |
Indications
| |||||
Kenvue Brands LLC | Liquid | Topical | 10 mg/1 mL | 2022 | |
Indications
| |||||
Kenvue Brands LLC | Spray | Topical | 20 mg/1 mL | 2022 | |
Indications
| |||||
Kenvue Brands LLC | Gel | Topical | 10 mg/1 mL | 2021 | |
Indications
| |||||
Shenzhen Yangan Technology Co. , Ltd. | Liquid | Topical | 1 g/100 mL | 2024 | |
Indications
| |||||
Guangzhou Zhicunxiu Cosmetics Co. , Ltd | Patch | Topical | 5 mg | 2024 | |
Indications
| |||||
Conopco Inc. | Cloth | Topical | 0.02 g/1 g | 2012 | |
Indications
| |||||
CONOPCO Inc. d/b/a Unilever | Soap | Topical | 0.01 g/1 g | 2012 | |
Indications
| |||||
NSE Products, Inc. | Gel | Topical | 5 g/1000 mL | 2002 | |
Indications
| |||||
NSE Products, Inc. | Liquid | Topical | 5 mg/1 mL | 2002 | |
Indications
| |||||
NSE Products, Inc | Gel | Topical | 5.5 g/1000 mL | 2013 | |
Indications
| |||||
NSE Products, Inc. | Liquid | Topical | 5 mg/1 mL | 2020 | |
Indications
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Patch | Topical | 17 g/100 1 | 2026 | |
Indications
| |||||
Ogee Inc | Solution | Topical | 0.5 g/100 mL | 2024 | |
Indications
| |||||
American Sales Company | Lotion | Topical | 20 mg/1 mL | 2014 | |
Indications
| |||||
CVS Pharmacy, Inc. | Lotion | Topical | 20 mg/1 mL | 2014 | |
Indications
| |||||
Meijer, Inc. | Lotion | Topical | 20.6 mg/1 mL | 2009 | |
Indications
| |||||
Publix Super Markets, Inc. | Lotion | Topical | 20.6 mg/1 mL | 2009 | |
Indications
| |||||
Rite Aid | Lotion | Topical | 20.6 mg/1 mL | 2009 | |
Indications
| |||||
Topco Associates LLC | Lotion | Topical | 20.6 mg/1 mL | 2009 | |
Indications
| |||||
United Natural Foods, Inc. dba UNFI | Lotion | Topical | 20.6 mg/1 mL | 2011 | |
Indications
| |||||
Walmart Inc. | Lotion | Topical | 20 mg/1 mL | 2025 | |
Indications
| |||||
Your Military Exchanges | Lotion | Topical | 20 mg/1 mL | 2009 | |
Indications
| |||||
Walmart | Liquid | Topical | 2 g/100 mL | 2023 | |
Indications
| |||||
Rejoice International | Gel | Topical | 3 g/150 g | 2013 | |
Indications
| |||||
Rejoice International | Gel | Topical | 3 g/150 g | 2013 | |
Indications
| |||||
Rejoice International | Gel | Topical | 4 mg/177 mg | 2013 | |
Indications
| |||||
Rejoice International | Gel | Topical | 4 mg/177 mg | 2013 | |
Indications
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Liquid | Topical | 17 g/100 mL | 2026 | |
Indications
| |||||
Walgreens Co. | Gel | Topical | 20 mg/1 mL | 2025 | |
Indications
| |||||
Walgreens Co. | Gel | Topical | 18 mg/1 mL | 2025 | |
Indications
| |||||
Scholls Wellness Company LLC | Disc | Topical | 0.4 g/1 g | 2023 | |
Indications
| |||||
HERRCO COSMETICS LIMITED | Gel | Topical | 2 g/100 mL | 2019 | |
Indications
| |||||
OSEA International, LLC | Cream | Topical | 1 mg/100 mL | 2023 | |
Indications
| |||||
Guangzhou Zanming Trading Co. , Ltd. | Liquid | Topical | 17 g/100 mL | 2025 | |
Indications
| |||||
Shantou Ouhoe Technology Co. , Ltd. | Patch | Topical | 0.02 g/100 g | 2025 | |
| |||||
Shantou Woodsleep Biotechnology Co. , Ltd. | Patch | Topical | 0.02 g/100 g | 2024 | |
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Liquid | Topical | 0.25 g/100 mL | 2026 | |
Indications
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD |
| Topical | 17 g/100 g – 17 g/100 mL | 2026 | |
Indications
| |||||
The Mentholatum Company | Solution | Topical | 5 mg/1 mL | 2019 | |
Indications
| |||||
The Mentholatum Company | Swab | Topical | 20 mg | 2021 | |
Indications
| |||||
The Mentholatum Company | Cream | Topical | 20 mg/1 mL | 2019 | |
Indications
| |||||
The Mentholatum Company | Swab | Topical | 20 mg | 2022 | |
Indications
| |||||
The Mentholatum Company | Patch | Topical | 5 mg | 2022 | |
Indications
| |||||
The Mentholatum Company | Swab | Topical | 20 mg | 2018 | |
Indications
| |||||
The Mentholatum Company | Cloth | Topical | 20 mg | 2024 | |
Indications
| |||||
The Mentholatum Company | Cloth | Topical | 20 mg | 2024 | |
Indications
| |||||
The Mentholatum Company | Swab | Topical | 20 mg | 2018 | |
Indications
| |||||
The Mentholatum Company | Gel | Topical | 18 mg/1 mL | 2024 | |
Indications
| |||||
The Mentholatum Company | Cloth | Topical | 5 mg | 2024 | |
Indications
| |||||
The Mentholatum Company | Liquid | Topical | 5 mg/1 mL | 2024 | |
Indications
| |||||
The Mentholatum Company | Liquid | Topical | 20 mg/1 mL | 2018 | |
Indications
| |||||
The Mentholatum Company | Cream | Topical | 20 mg/1 g | 2018 | |
Indications
| |||||
COLONIAL DAMES CO LTD | Lotion | Topical | 2 g/100 mL | 2014 | |
Indications
| |||||
Pacifica Beauty, LLC | Spray | Topical | 2 g/100 mg | 2023 | |
| |||||
Pacifica Beauty, LLC | Spray | Topical | 2 mg/100 g | 2024 | |
Indications
| |||||
Crown Laboratories | Soap | Topical | 20 mg/1 g | 2026 | |
Indications
| |||||
Crown Laboratories, Inc. | Aerosol, Spray | Topical | 2 g/100 g | 2024 | |
Indications
| |||||
Crown Laboratories, Inc. | Gel | Topical | 2 g/100 mL | 2025 | |
Indications
| |||||
Crown Laboratories, Inc. | Liquid | Topical | 2 g/100 mL | 2023 | |
Indications
| |||||
PAPATUI, LLC | Aerosol, Spray | Topical | 2 g/100 g | 2026 | |
Indications
| |||||
PAPATUI, LLC | Liquid | Topical | 2 g/100 mL | 2026 | |
Indications
| |||||
CP Skin Health Group, Inc | Gel | Topical | 2 g/100 mL | 2020 | |
Indications
| |||||
CP Skin Health Group, Inc. | Gel | Topical | 2 g/100 g | 2018 | |
Indications
| |||||
Peace Out LLC. | Patch | Topical | 0.5 mg | 2019 | |
Indications
| |||||
Peace Out LLC. | Patch | Topical | 0.359 mg | 2022 | |
Indications
| |||||
Peace Out LLC. | Patch | Topical | 0.359 mg | 2022 | |
Indications
| |||||
Peace Out LLC | Gel | Topical | 20 mg/1 mL | 2024 | |
Indications
| |||||
Peace Out LLC. | Patch | Topical | 0.1575 mg | 2022 | |
Indications
| |||||
Peace Out LLC. | Gel | Topical | 20 mg/1 mL | 2024 | |
Indications
| |||||
Peace Out LLC. | Lotion | Topical | 20 mg/1 mL | 2020 | |
Indications
| |||||
Peace Out LLC. | Patch | Topical | 0.14 mg | 2024 | |
Indications
| |||||
Peach & Lily, Inc. | Gel | Topical | 20 mg/1 mL | 2021 | |
Indications
| |||||
Peach & Lily Inc. | Liquid | Topical | 20 mg/1 mL | 2021 | |
Indications
| |||||
Peach & Lily, Inc. | Gel | Topical | 5 mg/1 mL | 2021 | |
Indications
| |||||
THG Beauty USA LLC | Cream | Topical | 2 g/100 mL | 2023 | |
Indications
| |||||
THG Beauty USA LLC | Cream | Topical | 0.5 g/100 mL | 2024 | |
Indications
| |||||
THG Beauty USA LLC | Gel | Topical | 2 g/100 mL | 2021 | |
Indications
| |||||
THG Beauty USA LLC | Liquid | Topical | 2 g/100 mL | 2022 | |
Indications
| |||||
THG Beauty USA LLC | Cream | Topical | 2 g/100 mL | 2022 | |
Indications
| |||||
THG Beauty USA LLC | Gel | Topical | 2 g/100 g | 2021 | |
Indications
| |||||
THG Beauty USA LLC | Cream | Topical | 0.5 g/100 mL | 2021 | |
Indications
| |||||
China Ningbo Shangge Cosmetics Technology Corp. | Liquid | Topical | 1 mg/100 mL | 2023 | |
Indications
| |||||
Rejoice International Corp. | Liquid | Topical | 1 mg/100 mL | 2023 | |
Indications
| |||||
Stonebridge Consultants LLC | Cream | Topical | 1.5 g/100 g | 2025 | |
Indications
| |||||
Guangzhou Huixue Biotechnology Co. , Ltd. | Liquid | Topical | 0.4 g/30 mL | 2026 | |
Indications
| |||||
PHARMAGEL INTERNATIONAL INC | Concentrate | Topical | 2 g/100 mL | 2015 | |
Indications
| |||||
PHARMAGEL INTERNATIONAL INC | Gel | Topical | 2 g/100 mL | 2015 | |
Indications
| |||||
PHARMAGEL INTERNATIONAL INC | Lotion | Topical | 1 g/100 mL | 2015 | |
Indications
| |||||
PHARMAGEL INTERNATIONAL INC | Liquid | Topical | 2 g/100 mL | 2016 | |
Indications
| |||||
The Mentholatum Company | Gel | Topical | 20 mg/1 mL | 2021 | |
Indications
| |||||
The Mentholatum Company | Gel | Topical | 20 mg/1 mL | 2021 | |
Indications
| |||||
The Mentholatum Company | Gel | Topical | 20 mg/1 g | 2022 | |
Indications
| |||||
The Mentholatum Company | Liquid | Topical | 20 mg/1 mL | 2013 | |
Indications
| |||||
The Mentholatum Company | Gel | Topical | 20 mg/1 g | 2013 | |
Indications
| |||||
The Mentholatum Company | Liquid | Topical | 20 mg/1 mL | 2012 | |
Indications
| |||||
The Mentholatum Company | Liquid | Topical | 20 mg/1 mL | 2012 | |
Indications
| |||||
The Mentholatum Company | Gel | Topical | 20 mg/1 g | 2012 | |
Indications
| |||||
Longway Technology (Guangzhou) Co. , Ltd. | Cream | Topical | 0.0108 g/1 g | 2025 | |
| |||||
Hangzhou Jingshen Trading Co. , Ltd. | Cream | Topical | 0.0108 g/1 g | 2025 | |
Indications
| |||||
Hangzhou Jingshen Trading Co. , Ltd. | Liquid | Topical | 20 mg/1 mL | 2025 | |
Indications
| |||||
COSMAX USA, CORP | Lotion | Topical | 5 mg/100 mL | 2025 | |
Indications
| |||||
Scholls Wellness Company LLC | Disc | Topical | 0.4 g/1 g | 2023 | |
Indications
| |||||
Premier Brands of America Inc. | Liquid | Topical | 0.17 mg/9.8 mL | 2022 | |
Indications
| |||||
Naturopathica Holistic Health | Liquid | Topical | 2 g/100 mL | 2021 | |
Indications
| |||||
Alchemee, LLC | Liquid | Topical | 2 g/100 mL | 2020 | |
Indications
| |||||
Alchemee, LLC | Spray | Topical | 2 mg/100 mL | 2024 | |
Indications
| |||||
Alchemee, LLC | Lotion | Topical | 0.5 mg/100 mL | 2012 | |
Indications
| |||||
Alchemee, LLC | Gel | Topical | 0.5 g/100 mL | 2013 | |
Indications
| |||||
Alchemee, LLC | Cream | Topical | 15 mg/1 mL | 2024 | |
Indications
| |||||
Alchemee, LLC | Cream | Topical | 1 mg/100 mL | 2015 | |
Indications
| |||||
Alchemee, LLC | Gel | Topical | 2 mg/100 mL | 2023 | |
Indications
| |||||
Alchemee, LLC | Liquid | Topical | 2 g/100 mL | 2017 | |
Indications
| |||||
THE PROACTIV COMPANY LLC | Lotion/Shampoo | Topical | 2 g/100 mL | 2010 | |
Indications
| |||||
Alchemee, LLC | Cream | Topical | 0.5 g/100 mL | 2013 | |
Indications
| |||||
Alchemee, LLC | Cream | Topical | 20 mg/1 mL | 2014 | |
Indications
| |||||
Alchemee, LLC | Cream | Topical | 1.5 g/100 mL | 2024 | |
Indications
| |||||
Alchemee, LLC | Cream | Topical | 2 g/100 mL | 2024 | |
Indications
| |||||
Alchemee, LLC | Liquid | Topical | 10 mg/1 mL | 2024 | |
Indications
| |||||
Rida LLC | Stick | Topical | 40 g/100 g | 2025 | |
Indications
| |||||
Proven Skincare | Cream | Topical | 2 g/100 g | 2024 | |
Indications
| |||||
Proven Skincare | Cream | Topical | 2 g/100 g | 2024 | |
Indications
| |||||
Rida LLC | Liquid | Topical | 3 g/100 mL | 2025 | |
Indications
| |||||
Shandong Yuyaotang Pharmaceutical Co. , Ltd | Liquid | Topical | 15 g/100 mL | 2025 | |
Indications
| |||||
Cosmetic Enterprises Ltd | Cream | Topical | 0.5 g/100 mL | 2018 | |
| |||||
Philosophy, Inc. | Cream | Topical | 0.5 µg/1 mL | 2018 | |
Indications
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Liquid | Topical | 17 g/100 mL | 2026 | |
Indications
| |||||
Jiangxi Hemei Pharmaceutical Co. , Ltd | Liquid | Topical | 17 g/100 mL | 2025 | |
Indications
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Liquid | Topical | 17 g/100 mL | 2026 | |
Indications
| |||||
Hainan Shengtaizhuo International Information Development Co. , LTD | Liquid | Topical | 2 mg/30 mL | 2025 | |
| |||||
Walmart Inc. | Liquid | Topical | 2 g/100 mL | 2017 | |
Indications
| |||||
Germa Products, LLC | Liquid | Topical | 170 mg/1 mL | 2019 | |
Indications
| |||||
Rael, Inc. | Emulsion | Topical | 15 mg/1 mL | 2024 | |
Indications
| |||||
Twincraft Inc. | Emulsion | Topical | 15 mg/1 mL | 2024 | |
Indications
| |||||
Jiashen International Trading Co. , Ltd. | Cream | Topical | 5 g/100 mL | 2025 | |
| |||||
Jiashen International Trading Co. , Ltd. | Liquid | Topical | 5 g/100 mL | 2025 | |
| |||||
Shenzhen Jiucai Ecommerce Co. , Ltd | Liquid | Topical | 5 g/100 mL | 2024 | |
Indications
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Liquid | Topical | 16 g/100 mL | 2026 | |
Indications
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Cream | Topical | 17 g/100 g | 2026 | |
Indications
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Patch | Topical | 40 g/100 1 | 2026 | |
Indications
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Cream | Topical | 17 g/100 g | 2026 | |
Indications
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Liquid | Topical | 17 g/100 mL | 2026 | |
Indications
| |||||
Topiderm, Inc. | Liquid | Topical | 20 mg/1 mL | 2016 | |
Indications
| |||||
Topiderm, Inc. | Liquid | Topical | 20 mg/1 mL | 2021 | |
Indications
| |||||
Topiderm, Inc. | Liquid | Topical | 20 mg/1 mL | 2019 | |
Indications
| |||||
Oars And Alps LLC | Swab | Topical | 0.005 mg/1 mL | 2022 | |
Indications
| |||||
SKIN PS Brands | Swab | Topical | 0.02 mg/1 mL | 2019 | |
Indications
| |||||
Murad, LLC | Solution | Topical | 2 g/100 mm | 2024 | |
Indications
| |||||
Dermalogica, LLC. | Oil | Topical | 2 mg/100 mL | 2024 | |
Indications
| |||||
Dermalogica, LLC. | Oil | Topical | 2 mg/100 mL | 2019 | |
Indications
| |||||
G. S. COSMECEUTICAL USA, INC. | Liquid | Topical | 2 g/100 g | 2019 | |
Indications
| |||||
Jiangxi Hemei Pharmaceutical Co. , Ltd | Liquid | Topical | 17 g/100 mL | 2025 | |
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Liquid | Topical | 17 g/100 mL | 2026 | |
| |||||
Skin PS Brands | Lotion | Topical | 20 mg/1 g | 2023 | |
Indications
| |||||
Acne Free, LLC | Cream | Topical | 0.02 g/1 g | 2024 | |
Indications
| |||||
AmerisourceBergen | Liquid | Topical | 0.17 g/9 mL | 2016 | |
Indications
| |||||
AmerisourceBergen Drug Corporation | Patch | Topical | 40 mg/4 1 | 2017 | |
Indications
| |||||
AmerisourceBergen Drug Corporation | Patch | Topical | 40 mg/9 1 | 2017 | |
Indications
| |||||
ARMY & AIR FORCE EXCHANGE SERVICE | Liquid | Topical | 0.17 mg/9 mL | 2017 | |
Indications
| |||||
Chain Drug Consortium, LLC | Patch | Topical | 40 mg/9 1 | 2003 | |
Indications
| |||||
Chain Drug Consortium, LLC | Liquid | Topical | 0.17 mg/15 mL | 2003 | |
Indications
| |||||
Chain Drug Consortium, LLC | Patch | Topical | 40 mg/4 1 | 2003 | |
Indications
| |||||
Chain Drug Consortium, LLC | Liquid | Topical | 0.17 mg/15 mL | 2003 | |
Indications
| |||||
Chain Drug Consortium, LLC | Patch | Topical | 40 mg/24 1 | 2009 | |
Indications
| |||||
Chain Drug Marketing Association | Patch | Topical | 400 mg/1 g | 2025 | |
Indications
| |||||
Chain Drug Marketing Association | Patch | Topical | 400 mg/1 g | 2025 | |
Indications
| |||||
Chain Drug Marketing Association | Patch | Topical | 400 mg/1 g | 2025 | |
Indications
| |||||
Chain Drug Marketing Association | Patch | Topical | 40 mg/4 1 | 2014 | |
Indications
| |||||
Chain Drug Marketing Association | Patch | Topical | 40 mg/9 1 | 2017 | |
Indications
| |||||
Chain Drug Marketing Association | Patch | Topical | 40 mg/24 1 | 2017 | |
Indications
| |||||
Chain Drug Marketing Association Inc. | Liquid | Topical | 0.17 g/9 mL | 2015 | |
Indications
| |||||
Chain Drug Marketing Association Inc. | Liquid | Topical | 0.17 g/9.8 mL | 2015 | |
Indications
| |||||
Chain Drug Marketing Association Inc. | Liquid | Topical | 170 mg/1 mL | 2025 | |
Indications
| |||||
Chain Drug Marketing Association Inc. | Liquid | Topical | 170 mg/1 mL | 2025 | |
Indications
| |||||
CVS Pharmacy | Patch | Topical | 40 mg/24 1 | 2014 | |
Indications
| |||||
CVS Pharmacy | Liquid | Topical | 0.17 mg/151 mL | 2014 | |
Indications
| |||||
CVS Pharmacy | Patch | Topical | 40 mg/4 1 | 2014 | |
Indications
| |||||
CVS Pharmacy | Patch | Topical | 40 mg/18 1 | 2014 | |
Indications
| |||||
CVS Pharmacy | Liquid | Topical | 0.17 mg/15 mL | 2014 | |
Indications
| |||||
CVS Pharmacy | Patch | Topical | 40 mg/9 1 | 2014 | |
Indications
| |||||
CVS Pharmacy | Patch | Topical | 40 mg/12 1 | 2020 | |
Indications
| |||||
CVS Pharmacy | Patch | Topical | 40 mg/9 1 | 2014 | |
Indications
| |||||
CVS Pharmacy | Patch | Topical | 40 mg/4 1 | 2014 | |
Indications
| |||||
CVS Pharmacy | Patch | Topical | 40 mg/6 1 | 2018 | |
Indications
| |||||
CVS Pharmacy | Patch | Topical | 40 mg/12 1 | 2022 | |
Indications
| |||||
Discount Drug Mart | Liquid | Topical | 0.17 mg/9 mL | 2017 | |
Indications
| |||||
Discount Drug Mart | Patch | Topical | 40 mg/4 1 | 2017 | |
Indications
| |||||
Foodhold USA | Patch | Topical | 40 mg/4 1 | 2017 | |
Indications
| |||||
Foodhold USA | Patch | Topical | 40 mg/9 1 | 2017 | |
Indications
| |||||
Foodhold USA | Liquid | Topical | 0.17 mg/9.8 g | 2017 | |
Indications
| |||||
Foodhold USA | Liquid | Topical | 0.17 g/9 mL | 2017 | |
Indications
| |||||
Foodhold USA | Gel | Topical | 0.17 g/7 g | 2017 | |
Indications
| |||||
FSA Store Inc. | Patch | Topical | 400 mg/1 g | 2025 | |
Indications
| |||||
FSA Store Inc. | Liquid | Topical | 170 mg/1 mL | 2025 | |
Indications
| |||||
FSA Store Inc. | Liquid | Topical | 170 mg/1 mL | 2025 | |
Indications
| |||||
Geiss Destin & Dunn Inc. | Liquid | Topical | 0.17 g/9 mL | 2015 | |
Indications
| |||||
Geiss, Destin & Dunn, Inc. | Liquid | Topical | 0.17 g/9.8 mL | 2015 | |
Indications
| |||||
Harris Teeter, LLC | Patch | Topical | 40 mg/9 1 | 2017 | |
Indications
| |||||
Harris Teeter, LLC | Patch | Topical | 40 mg/4 1 | 2012 | |
Indications
| |||||
Harris Teeter, LLC | Liquid | Topical | 0.17 mg/9.8 mL | 2017 | |
Indications
| |||||
Harris Teeter, LLC | Liquid | Topical | 0.17 mg/9 mL | 2017 | |
Indications
| |||||
HEB | Patch | Topical | 40 mg/4 1 | 2017 | |
Indications
| |||||
HEB | Patch | Topical | 40 mg/9 1 | 2017 | |
Indications
| |||||
Hudson Health LLC | Patch | Topical | 400 mg/1 g | 2018 | |
Indications
| |||||
Hudson Health LLC | Patch | Topical | 40 mg/24 1 | 2018 | |
Indications
| |||||
Hudson Health LLC | Patch | Topical | 40 mg/4 1 | 2018 | |
Indications
| |||||
Hudson Health LLC | Liquid | Topical | 0.17 mg/9 mL | 2018 | |
Indications
| |||||
Hudson Health LLC | Liquid | Topical | 0.17 mg/9.8 mL | 2018 | |
Indications
| |||||
Hudson Health LLC | Patch | Topical | 40 mg/18 1 | 2018 | |
Indications
| |||||
HY-VEE, INC | Patch | Topical | 400 mg/1 g | 2025 | |
Indications
| |||||
Kroger Co. | Patch | Topical | 40 mg/18 1 | 2012 | |
Indications
| |||||
Kroger Co. | Patch | Topical | 40 mg/9 1 | 2012 | |
Indications
| |||||
Kroger Co. | Liquid | Topical | 0.17 mg/9 mL | 2017 | |
Indications
| |||||
Kroger Co. | Liquid | Topical | 0.17 mg/9 mL | 2017 | |
Indications
| |||||
LEADER/ Cardinal Health 110, Inc. | Patch | Topical | 400 mg/1 g | 2018 | |
Indications
| |||||
LEADER/ Cardinal Health 110, Inc. | Liquid | Topical | 17 g/100 mL | 2018 | |
Indications
| |||||
LEADER/ Cardinal Health 110, Inc. | Patch | Topical | 400 mg/1 g | 2018 | |
Indications
| |||||
LEADER/ Cardinal Health 110, Inc. | Liquid | Topical | 17 g/100 mL | 2018 | |
Indications
| |||||
Meijer Distribution Inc | Patch | Topical | 40 mg/24 1 | 2012 | |
Indications
| |||||
Meijer Distribution Inc | Liquid | Topical | 0.17 g/9 mL | 2015 | |
Indications
| |||||
Premier Brands of America Inc. | Patch | Topical | 40 mg/4 1 | 2013 | |
Indications
| |||||
Premier Brands of America Inc. | Patch | Topical | 400 mg/1 g | 2025 | |
Indications
| |||||
Premier Brands of America Inc. | Patch | Topical | 400 mg/1 g | 2022 | |
Indications
| |||||
Premier Brands of America Inc. | Patch | Topical | 40 mg/18 1 | 2013 | |
Indications
| |||||
Premier Brands of America Inc. | Patch | Topical | 40 mg/12 1 | 2022 | |
Indications
| |||||
Premier Brands of America Inc. | Patch | Topical | 40 mg/9 1 | 2013 | |
Indications
| |||||
Rite Aid Corporation | Plaster | Topical | 0.4 g/18 1 | 2017 | |
Indications
| |||||
Rite Aid Corporation | Patch | Topical | 40 mg/4 1 | 2017 | |
Indications
| |||||
RITE AID CORPORATION | Liquid | Topical | 0.17 g/9 mL | 2017 | |
Indications
| |||||
Rite Aid Corporation | Patch | Topical | 40 mg/9 1 | 2017 | |
Indications
| |||||
Rite Aid Corporation | Patch | Topical | 40 mg/18 1 | 2017 | |
Indications
| |||||
Rite Aid Corporation | Liquid | Topical | 0.17 mg/9.8 mL | 2017 | |
Indications
| |||||
SANSAR, LLC | Cream | Topical | 12 g/100 g | 2025 | |
Indications
| |||||
Target Corporation | Patch | Topical | 400 mg/1 g | 2025 | |
Indications
| |||||
Target Corporation | Liquid | Topical | 170 mg/1 mL | 2025 | |
Indications
| |||||
Topco Associates LLC | Liquid | Topical | 0.17 mg/9.8 mL | 2012 | |
Indications
| |||||
Topco Associates LLC | Patch | Topical | 40 mg/24 1 | 2017 | |
Indications
| |||||
Topco Associates LLC | Patch | Topical | 40 mg/4 1 | 2017 | |
Indications
| |||||
Topco Associates LLC | Liquid | Topical | 20 mg/1 mL | 2026 | |
Indications
| |||||
Topco Associates LLC | Liquid | Topical | 0.17 mg/9 mL | 2017 | |
Indications
| |||||
Topco Associates LLC | Liquid | Topical | 5 mg/1 mL | 2009 | |
Indications
| |||||
Topco Associates LLC | Patch | Topical | 40 mg/9 1 | 2012 | |
Indications
| |||||
Topco Associates LLC | Gel | Topical | 0.17 g/7 g | 2014 | |
Indications
| |||||
Topco Associates LLC | Plaster | Topical | 0.4 g/18 1 | 2017 | |
Indications
| |||||
Topco Associates LLC | Patch | Topical | 40 mg/4 1 | 2012 | |
Indications
| |||||
United Natural Foods, Inc. | Patch | Topical | 0.4 g/1 g | 2017 | |
Indications
| |||||
United Natural Foods, Inc. | Patch | Topical | 0.4 g/1 g | 2017 | |
Indications
| |||||
United Natural Foods, Inc. dba UNFI | Patch | Topical | 40 mg/4 1 | 2017 | |
Indications
| |||||
United Natural Foods, Inc. dba UNFI | Patch | Topical | 40 mg/9 1 | 2017 | |
Indications
| |||||
VALU MERCHANDISERS, CO | Patch | Topical | 40 mg/4 1 | 2017 | |
Indications
| |||||
VALU MERCHANDISERS, CO | Liquid | Topical | 0.17 g/9 mL | 2017 | |
Indications
| |||||
VALU MERCHANDISERS, CO | Gel | Topical | 0.17 g/7 g | 2017 | |
Indications
| |||||
VALU MERCHANDISERS, CO | Liquid | Topical | 0.17 mg/9.8 mL | 2017 | |
Indications
| |||||
VALU MERCHANDISERS, CO | Patch | Topical | 40 mg/4 1 | 2014 | |
Indications
| |||||
VALU MERCHANDISERS, CO | Patch | Topical | 40 mg/9 1 | 2017 | |
Indications
| |||||
Wal-Mart Stores Inc | Patch | Topical | 40 mg/9 1 | 2019 | |
Indications
| |||||
Wal-Mart Stores, Inc. | Liquid | Topical | 170 mg/1 mL | 2024 | |
Indications
| |||||
Wal-Mart Stores, Inc. | Liquid | Topical | 0.17 g/1 g | 2014 | |
Indications
| |||||
Walgreen Company | Patch | Topical | 40 mg/9 1 | 2008 | |
Indications
| |||||
Walgreen Company | Patch | Topical | 40 mg/18 1 | 2013 | |
Indications
| |||||
Walgreen Company | Liquid | Topical | 0.17 g/1 g | 2008 | |
Indications
| |||||
Walgreen Company | Liquid | Topical | 0.17 g/1 g | 2008 | |
Indications
| |||||
Walgreen Company | Gel | Topical | 0.17 g/7 g | 2012 | |
Indications
| |||||
Walgreen Company | Patch | Topical | 40 mg/4 1 | 2012 | |
Indications
| |||||
Walgreens Company | Patch | Topical | 40 mg/9 1 | 2013 | |
Indications
| |||||
Walgreens Company | Patch | Topical | 40 mg/12 1 | 2022 | |
Indications
| |||||
Your Military Exchanges | Liquid | Topical | 5 mg/1 mL | 2009 | |
Indications
| |||||
Deciem | Lotion | Topical | 20 mg/1 mL | 2025 | |
| |||||
ASO Pharmaceutical Co. , ltd. | Plaster | Topical | 0.4 g/1 g | 2025 | |
| |||||
COMFMET LIMITED | Cream | Topical | 2.5 g/100 g | 2024 | |
Indications
| |||||
Bentley Laboratories, LLC | Gel | Topical | 5 mg/1 mL | 2023 | |
Indications
| |||||
Skin PS Brands | Gel | Topical | 5 mg/1 g | 2023 | |
Indications
| |||||
Skin PS Brands | Patch | Topical | 5 mg/1 g | 2023 | |
Indications
| |||||
ASO Pharmaceutical Co. Ltd. | Strip | Topical | 40 mg | 2009 | |
Indications
| |||||
CVS Pharmacy | Strip | Topical | 40 mg | 2016 | |
Indications
| |||||
CosMedical Technologies | Liquid | Topical | 20 mg/1 mL | 2015 | |
Indications
| |||||
Malin and Goetz Inc | Gel | Topical | 2 g/100 mL | 2022 | |
| |||||
CONTROL CORRECTIVE SKINCARE INC | Lotion | Topical | 2 g/100 mL | 2016 | |
| |||||
Toprail Chp Llc | Liquid | Topical | 0.17 g/9 mL | 2025 | |
Indications
| |||||
Shenzhen Xinxin Yunhai Technology Co. , Ltd. | Patch | Topical | 40 g/100 1 | 2024 | |
Indications
| |||||
Shenzhen Xinxin Yunhai Technology Co. , Ltd. | Liquid | Topical | 5 g/100 mL | 2024 | |
Indications
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Patch | Topical | 40 g/100 1 | 2026 | |
Indications
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Liquid | Topical | 17 g/100 mL | 2026 | |
Indications
| |||||
Sato Pharmaceutical Co. , Ltd. | Liquid | Topical | 12 g/100 mL | 1987 | |
Indications
| |||||
Dermala Inc | Liquid | Topical | 0.01 mg/1 mg | 2021 | |
Indications
| |||||
Scholls Wellness Company LLC | Disc | Topical | 0.4 g/1 g | 2021 | |
Indications
| |||||
Scholls Wellness Company LLC | Disc | Topical | 0.4 g/1 g | 2021 | |
Indications
| |||||
Scholls Wellness Company LLC | Disc | Topical | 0.4 g/1 g | 2021 | |
Indications
| |||||
Scholls Wellness Company LLC | Disc | Topical | 0.4 g/1 g | 2021 | |
Indications
| |||||
Scholls Wellness Company LLC | Disc | Topical | 4 mg | 2021 | |
Indications
| |||||
Creative Foam Corporation | Plaster | Topical | 40 mg/100 mg | 2020 | |
Indications
| |||||
ASPIRE BRANDS INC | Gel | Topical | 0.5 g/100 mL | 2020 | |
Indications
| |||||
Melaleuca, Inc. | Soap | Topical | 0.6 g/30 mL | 2024 | |
Indications
| |||||
Melaleuca, Inc. | Liquid | Topical | 1.8 g/180 mL | 2024 | |
Indications
| |||||
Flageoli Limited | Lotion | Topical | 10 mg/1 mL | 2018 | |
Indications
| |||||
Jiangxi Hemei Pharmaceutical Co. , Ltd | Cream | Topical | 17 g/100 g | 2025 | |
Indications
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Cream | Topical | 17 g/100 g | 2026 | |
Indications
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Liquid | Topical | 17 g/100 mL | 2026 | |
Indications
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Liquid | Topical | 1 g/100 mL | 2026 | |
Indications
| |||||
Jiangxi Hemei Pharmaceutical Co. , Ltd | Liquid | Topical | 17 g/100 mL | 2025 | |
Indications
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Liquid | Topical | 17 g/100 mL | 2026 | |
Indications
| |||||
Omnilife USA, Inc. | Gel | Topical | 2 g/100 mL | 2024 | |
Indications
| |||||
Codex Labs Corporation | Cream | Topical | 2 g/100 g | 2023 | |
Indications
| |||||
Codex Labs Corporation | Cream | Topical | 2 g/100 g | 2023 | |
Indications
| |||||
Conopco d/b/a/ Unilever | Solution/ Drops | Topical | 2 g/100 mL | 2025 | |
Indications
| |||||
Guangzhou Yixin Cross-border E-commerce Co. , Ltd. | Ointment | Cutaneous | 1 g/20 g | 2024 | |
Indications
| |||||
SHISEIDO AMERICAS CORPORATION | Gel | Topical | 0.1 g/20 mL | 2021 | |
Indications
| |||||
SAFEWAY, INC. | Emulsion | Topical | 20 mg/1 g | 2014 | |
Indications
| |||||
Safeway, Inc. | Lotion | Topical | 20 mg/1 mL | 2014 | |
Indications
| |||||
ALPHA PLANTS INC | Cream | Topical | 20 mg/1 mL | 2022 | |
Indications
| |||||
Sinsin Pharmaceutical Co. , Ltd. | Patch | Topical | 25.6 mg/100 1 | 2022 | |
Indications
| |||||
Matrix Beauty LLC | Spray | Topical | 0.5 g/100 g | 2025 | |
Indications
| |||||
Shenzhen Yangan Technology Co. , Ltd. | Patch | Topical | 1 mg/100 mg | 2024 | |
Indications
| |||||
Skin Laundry Holdings, Inc. | Gel | Topical | 20 mg/1 mL | 2023 | |
Indications
| |||||
Allergan, Inc. | Liquid | Topical | 20 mg/1 mL | 2013 | |
Indications
| |||||
Shenzhen Hengkaifeng Commerce and Trade Co. , Ltd | Cream | Topical | 10 mg/1 g | 2024 | |
| |||||
Shenzhen Hengkaifeng Commerce and Trade Co. , Ltd | Patch | Topical | 25 g/100 g | 2024 | |
Indications
| |||||
Shenzhen Yikai Electronic Technology Co. , Ltd. | Patch | Topical | 25 g/100 g | 2024 | |
Indications
| |||||
Dongkou County Hecheng Network Technology Co. , Ltd. | Patch | Topical | 2 g/100 1 | 2024 | |
Indications
| |||||
Shenzhen Hanchuan e-commerce Co. , Ltd | Patch | Topical | 2 g/100 1 | 2024 | |
Indications
| |||||
Shenzhen Rongxing Trading Co. , Ltd. | Patch | Topical | 2 g/100 g | 2024 | |
| |||||
Shenzhen Hengkaifeng Commerce and Trade Co. , Ltd | Liquid | Topical | 0.1 g/100 mL | 2024 | |
Indications
| |||||
Dongkou County Hecheng Network Technology Co. , Ltd. | Liquid | Topical | 10 g/100 mL | 2024 | |
Indications
| |||||
Guangzhou ChuanMa International Trading Co. , Ltd. | Patch | Topical | 15 mg/1 g | 2025 | |
| |||||
Guangzhou ChuanMa International Trading Co. , Ltd. | Patch | Topical | 5 g/100 g | 2025 | |
Indications
| |||||
Xi'an Chuancheng Medical Technology Co. , Ltd. | Patch | Topical | 0.75 g/15 g | 2024 | |
| |||||
Xi'an Chuancheng Medical Technology Co. , Ltd. | Patch | Topical | 0.2 g/4 g | 2024 | |
| |||||
Shenzhen Hengkaifeng Commerce and Trade Co. , Ltd | Liquid | Topical | 5 g/100 mL | 2024 | |
Indications
| |||||
L'Oreal USA Products Inc | Lotion | Topical | 15 mg/1 mL | 2005 | |
Indications
| |||||
L'Oreal USA Products Inc | Cream | Topical | 20 mg/1 mL | 2017 | |
Indications
| |||||
L'Oreal USA Products Inc | Solution | Topical | 5 mg/1 mL | 2020 | |
Indications
| |||||
Cosmetique Active Production | Solution | Topical | 5 mg/1 mL | 2020 | |
Indications
| |||||
SKINKURE, LLC | Gel | Topical | 20 mg/1 mL | 2024 | |
Indications
| |||||
Skinlycious Pte Ltd | Liquid | Topical | 2 g/100 mL | 2021 | |
Indications
| |||||
Allergan, Inc. | Lotion | Topical | 20 mg/1 mL | 2024 | |
Indications
| |||||
Owen Biosciences Inc. | Liquid | Topical | 2 g/100 g | 2019 | |
Indications
| |||||
ASPIRE BRANDS INC | Liquid | Topical | 0.5 g/100 mL | 2016 | |
Indications
| |||||
Respect Manufacturing Corporation | Gel | Topical | 0.15 g/30 g | 2024 | |
Indications
| |||||
PERENNEBELL Co. , Ltd. | Cream | Topical | 2 g/400 g | 2023 | |
Indications
| |||||
PERENNEBELL Co. , Ltd. | Cream | Topical | 0.5 g/100 g | 2023 | |
Indications
| |||||
Guangdong Quadrant Ecological Technology Co. , Ltd. | Liquid | Topical | 0.17 g/1 mL | 2026 | |
Indications
| |||||
I World LLC | Lotion | Topical | 5.4 mg/1 mL | 2025 | |
Indications
| |||||
I World LLC | Lotion | Topical | 5 mg/1 g | 2025 | |
Indications
| |||||
I World LLC | Lotion | Topical | 11 mg/1 mL | 2025 | |
Indications
| |||||
Henan Toudaorong Biotechnology Co. , Ltd. | Liquid | Topical | 15 g/100 mL | 2025 | |
| |||||
China Ningbo Shangge Cosmetics Technology Corp. | Cream | Topical | 2 g/100 g | 2024 | |
Indications
| |||||
Rejoice International Corp. | Cream | Topical | 2 g/100 g | 2024 | |
Indications
| |||||
ACNEFREE, LLC | Patch | Topical | 1.24 g | 2023 | |
Indications
| |||||
The Honest Company, Inc | Gel | Topical | 2 g/100 mL | 2022 | |
Indications
| |||||
CONOPCO Inc. d/b/a Unilever | Emulsion | Topical | 0.02 g/1 g | 2021 | |
Indications
| |||||
CONOPCO Inc. d/b/a Unilever | Emulsion | Topical | 0.01 g/1 g | 2021 | |
Indications
| |||||
CONOPCO Inc. d/b/a Unilever | Lotion | Topical | 2 g/100 mL | 2021 | |
Indications
| |||||
CONOPCO Inc. d/b/a Unilever | Lotion | Topical | 0.02 g/1 g | 2021 | |
Indications
| |||||
CONOPCO Inc. d/b/a Unilever | Lotion | Topical | 0.02 g/1 g | 2022 | |
Indications
| |||||
Starface World, Inc. | Gel | Topical | 20 mg/1 mL | 2026 | |
Indications
| |||||
ASPIRE BRANDS INC | Gel | Topical | 2 g/100 mL | 2020 | |
Indications
| |||||
Blistex Inc | Liquid | Topical | 0.5 g/100 mL | 2012 | |
Indications
| |||||
Blistex Inc. | Liquid | Topical | 2 g/100 mL | 2012 | |
Indications
| |||||
Accupac LLC | Liquid | Topical | 1 g/100 mL | 2022 | |
Indications
| |||||
Blistex Inc | Liquid | Topical | 1 g/100 mL | 2022 | |
Indications
| |||||
Blistex Inc | Liquid | Topical | 2 g/100 mL | 2020 | |
Indications
| |||||
Shenzhen Yikai Electronic Technology Co. , Ltd. | Patch | Topical | 12 g/100 1 | 2023 | |
Indications
| |||||
Shenzhen Yikai Electronic Technology Co. , Ltd. | Liquid | Topical | 12 g/100 mL | 2023 | |
Indications
| |||||
Sunday Riley Modern Skincare, LLC | Liquid | Topical | 20 mg/1 mL | 2025 | |
Indications
| |||||
Sunday Riley Modern Skincare, LLC | Oil | Topical | 15 mg/1 mL | 2017 | |
Indications
| |||||
ORIGINS NATURAL RESOURCES INC. | Gel | Topical | 15 mg/1 mL | 2012 | |
Indications
| |||||
Shenzhen Xinxin Yunhai Technology Co. , Ltd. | Stick | Topical | 40 g/100 1 | 2026 | |
Indications
| |||||
Guangzhou Yixin Cross-border E-commerce Co. , Ltd. | Gel | Cutaneous | 0.5 g/0.5 g | 2024 | |
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Liquid | Topical | 17 g/100 mL | 2026 | |
Indications
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Liquid | Topical | 1 g/100 mL | 2026 | |
Indications
| |||||
Guangzhou ChuanMa International Trading Co. , Ltd. | Liquid | Topical | 8 g/100 mL | 2025 | |
| |||||
Hengyang Chuangjiujia Trading Co. , Ltd. | Liquid | Topical | 10 g/100 mL | 2025 | |
Indications
| |||||
Shenzhen Yangan Technology Co. , Ltd. | Liquid | Topical | 5 mg/100 mL | 2025 | |
| |||||
Shenzhen Yangan Technology Co. , Ltd. | Liquid | Topical | 5 mg/100 mL | 2025 | |
Indications
| |||||
Shenzhen Yangan Technology Co. , Ltd. | Liquid | Topical | 5 mg/100 mL | 2025 | |
Indications
| |||||
TARGET CORPORATION | Lotion | Topical | 5 mg/1 mL | 2024 | |
Indications
| |||||
TARGET CORPORATION | Lotion | Topical | 20 mg/1 mL | 2016 | |
Indications
| |||||
TARGET CORPORATION | Liquid | Topical | 20 mg/1 mL | 2024 | |
Indications
| |||||
SANSAR, LLC | Gel | Topical | 12 g/100 mL | 2025 | |
Indications
| |||||
Hubei Redrui Building Materials Co. , Ltd. | Liquid | Topical | 3.6 g/30 g | 2025 | |
Indications
| |||||
RNA PHARMA, LLC | Oil | Topical | 0.02 g/1 g | 2025 | |
| |||||
RNA PHARMA, LLC | Lotion/Shampoo | Topical | 0.02 g/1 g | 2025 | |
| |||||
RNA PHARMA, LLC | Lotion/Shampoo | Topical | 0.02 g/1 g | 2025 | |
| |||||
L’Oreal USA Products Inc | Lotion | Topical | 15 mg/1 mL | 2024 | |
Indications
| |||||
L'Oreal USA Products Inc | Gel | Topical | 20 mg/1 mL | 2022 | |
Indications
| |||||
L'Oreal USA Products Inc | Gel | Topical | 20 mg/1 mL | 2022 | |
Indications
| |||||
L'Oreal USA Products Inc | Liquid | Topical | 20 mg/1 mL | 2021 | |
Indications
| |||||
L'Oreal USA Products Inc | Liquid | Topical | 20 mg/1 mL | 2021 | |
Indications
| |||||
L'Oreal USA Products Inc | Solution | Topical | 20 mg/1 mL | 2023 | |
Indications
| |||||
Brand Evangelists for Beauty Limited | Emulsion | Topical | 20 mg/1 mL | 2025 | |
Indications
| |||||
Brand Evangelists for Beauty Ltd | Gel | Topical | 20 mg/1 mL | 2021 | |
Indications
| |||||
Brand Evangelists for Beauty Ltd | Gel | Topical | 20 mg/1 mL | 2021 | |
Indications
| |||||
Brand Evangelists for Beauty Ltd | Gel | Topical | 20 mg/1 mL | 2021 | |
Indications
| |||||
Brand Evangelists for Beauty Ltd | Cream | Topical | 10 mg/1 mL | 2020 | |
Indications
| |||||
Brand Reach Collective LLC | Cream | Cutaneous | 20 mg/1 mL | 2025 | |
Indications
| |||||
Brand Reach Collective LLC | Cream | Cutaneous | 20 mg/1 mL | 2025 | |
Indications
| |||||
Noon Aesthetics M. R. Ltd | Cream | Topical | 1 g/50 g | 2020 | |
Indications
| |||||
Tiege Hanley | Cream | Topical | 20 mg/1 mL | 2024 | |
Indications
| |||||
Tiege Hanley | Aerosol, Spray | Topical | 2 g/100 g | 2025 | |
Indications
| |||||
Drmtlgy, LLC | Cloth | Topical | 2 g/100 g | 2025 | |
Indications
| |||||
COMMERCE OPERATIONS LLC | Cream | Topical | 5 g/100 g | 2025 | |
| |||||
Topiderm, Inc. | Liquid | Topical | 20 mg/1 mL | 2024 | |
Indications
| |||||
ASPIRE BRANDS INC | Gel | Topical | 2 g/100 mL | 2020 | |
Indications
| |||||
Guangdong Miaolian Cosmetics Co. , Ltd. |
| Topical | 0.001 mg/100 mL – 0.24 mg/100 g | 2025 | |
| |||||
Guangdong Meizhiyuan Biotechnology Co. , Ltd. | Gel | Topical | 0.02 g/1 mL | 2025 | |
Indications
| |||||
Jiashen International Trade Limited | Liquid | Topical | 1.5 g/30 mL | 2025 | |
| |||||
Jiashen International Trading Co. , Ltd. | Cream | Cutaneous | 100 mg/20 g | 2024 | |
| |||||
Tula Life LLC | Liquid | Topical | 2 g/100 g | 2024 | |
Indications
| |||||
The Procter & Gamble Manufacturing Company | Disc | Topical | 2 g/100 1 | 2025 | |
Indications
| |||||
The Procter & Gamble Manufacturing Company | Cream | Topical | 2 g/100 mL | 2025 | |
Indications
| |||||
The Procter & Gamble Manufacturing Company | Gel | Topical | 2 g/100 mL | 2025 | |
Indications
| |||||
Shenzhen Xinxin Yunhai Technology Co. , Ltd. | Patch | Topical | 40 g/100 1 | 2024 | |
Indications
| |||||
Kairos Trading Inc | Patch | Topical | 40 mg/100 g | 2023 | |
Indications
| |||||
Kairos Trading Inc | Patch | Topical | 40 g/100 1 | 2023 | |
Indications
| |||||
UFORIC HEALTH LLC | Solution | Topical | 50 mg/1 mL | 2022 | |
Indications
| |||||
Guangzhou Zanming Trading Co. , Ltd. | Liquid | Topical | 17 g/100 mL | 2025 | |
Indications
| |||||
Shenzhen Xinxin Yunhai Technology Co. , Ltd. | Liquid | Topical | 5 g/100 mL | 2024 | |
Indications
| |||||
APR BEAUTY GROUP INC | Gel | Topical | 20 mg/1 g | 2024 | |
| |||||
ULTRACEUTICALS PTY LIMITED | Lotion | Topical | 0.5 g/100 mL | 2019 | |
| |||||
ULTRACEUTICALS PTY LIMITED | Lotion | Topical | 2 g/100 mL | 2019 | |
| |||||
Rodan & Fields | Cream | Topical | 0.005 g/1 mL | 2020 | |
Indications
| |||||
Allure Labs | Liquid | Topical | 20 mg/1 g | 2026 | |
Indications
| |||||
TARGET CORPORATION | Emulsion | Topical | 20 mg/1 g | 2013 | |
Indications
| |||||
TARGET CORPORATION | Liquid | Topical | 20 mg/1 mL | 2013 | |
Indications
| |||||
TARGET CORPORATION | Liquid | Topical | 5 mg/1 mL | 2014 | |
Indications
| |||||
Vanibiss Inc | Cream | Topical | 2 g/100 mL | 2023 | |
Indications
| |||||
Vanibiss Inc | Cream | Topical | 20 mg/1 mL | 2021 | |
Indications
| |||||
Vanish Skincare LLC | Patch | Topical | 0.5 mg/100 mg | 2025 | |
Indications
| |||||
Guangzhou Oupeng Cosmetics Co. , Ltd. | Patch |
| 1.5 g/100 g | 2025 | |
Indications
| |||||
The Podiatree Company | Gel | Topical | 17 g/100 g | 2015 | |
Indications
| |||||
Germa Products, LLC | Liquid | Topical | 170 mg/1 mL | 2019 | |
Indications
| |||||
Clinical Therapeutic Solutions | Liquid | Topical | 170 mg/1 mL | 2013 | |
Indications
| |||||
VIADERMA DISTRIBUTION INC | Solution | Topical | 20 mg/1 mL | 2025 | |
Indications
| |||||
ViaDerma Distribution, Inc. | Ointment | Topical | 20 mg/1 g | 2025 | |
Indications
| |||||
L'Oreal USA Products Inc | Gel | Topical | 20 mg/1 mL | 2023 | |
Indications
| |||||
COSMETIQUE ACTIVE PRODUCTION | Gel | Topical | 20 mg/1 mL | 2023 | |
Indications
| |||||
COSMETIQUE ACTIVE PRODUCTION | Lotion | Topical | 10 mg/1 mL | 2022 | |
Indications
| |||||
L'Oreal USA Products Inc | Lotion | Topical | 10 mg/1 mL | 2022 | |
Indications
| |||||
COSMETIQUE ACTIVE PRODUCTION | Gel | Topical | 5 mg/1 mL | 2024 | |
Indications
| |||||
L'Oreal USA Products Inc | Gel | Topical | 5 mg/1 mL | 2024 | |
Indications
| |||||
L'Oreal USA Products Inc | Cream | Topical | 5 mg/1 mL | 2012 | |
Indications
| |||||
L'Oreal USA Products Inc | Gel | Topical | 20 mg/1 mL | 2020 | |
Indications
| |||||
COSMETIQUE ACTIVE PRODUCTION | Gel | Topical | 20 mg/1 mL | 2020 | |
Indications
| |||||
L'Oreal USA Products Inc | Gel | Topical | 5 mg/1 mL | 2020 | |
Indications
| |||||
COSMETIQUE ACTIVE PRODUCTION | Gel | Topical | 5 mg/1 mL | 2020 | |
Indications
| |||||
Pure Source, LLC | Cream | Topical | 17 g/100 g | 2014 | |
Indications
| |||||
Shenzhen Lanxi Trading Co. , Ltd. | Liquid | Topical | 0.12 g/1 mL | 2026 | |
Indications
| |||||
WALGREEN COMPANY | Gel | Topical | 20 mg/1 mL | 2023 | |
Indications
| |||||
WALGREEN COMPANY | Liquid | Topical | 30 mg/1 mL | 2020 | |
Indications
| |||||
WALGREEN COMPANY | Emulsion | Topical | 20 mg/1 g | 2020 | |
Indications
| |||||
WALGREENS Co | Strip | Topical | 4.42 mg | 2013 | |
Indications
| |||||
WALGREEN COMPANY | Lotion | Topical | 30 mg/1 mL | 2020 | |
Indications
| |||||
Walgreen Co. | Patch | Topical | 0.23 g | 2023 | |
Indications
| |||||
Walgreen Co. | Strip | Topical | 1.35 mg | 2023 | |
Indications
| |||||
Walgreen Co. | Patch | Topical | 0.54 mg | 2023 | |
Indications
| |||||
Walgreen Company | Lotion | Topical | 20 mg/1 mL | 2022 | |
Indications
| |||||
WALGREEN COMPANY | Lotion | Topical | 20 mg/1 mL | 2024 | |
Indications
| |||||
Guangdong Joyan Biological Technology Co. , Ltd | Liquid | Topical | 0.17 g/1 mL | 2025 | |
Indications
| |||||
Guangzhou Fengda Technology Co. , Ltd. | Liquid | Topical | 2.4 mg/12 mL | 2025 | |
| |||||
Shenzhen Haizhida E-commerce Co. , Ltd | Patch | Topical | 0.4 g | 2025 | |
Indications
| |||||
Shenzhen Yangan Technology Co. , Ltd. | Liquid | Topical | 5 g/100 mL | 2024 | |
Indications
| |||||
Shanghai Yijing Medical Technology Co. , Ltd. | Cream | Topical | 1.5 g/30 g | 2025 | |
Indications
| |||||
Guangzhou Hechuang Commercial Service Co. , Ltd. | Liquid |
| 8 g/100 g | 2025 | |
Indications
| |||||
IBP CORP CO. LTD. | Liquid | Topical | 1 g/100 mL | 2024 | |
Indications
| |||||
Gaoye Marketing Inc | Liquid | Topical | 7 g/100 mL | 2025 | |
Indications
| |||||
Shenzhen Gaoye E-commerce Co. , Ltd | Liquid | Topical | 7 g/100 mL | 2024 | |
Indications
| |||||
Shenzhen Gaoye E-commerce Co. , Ltd | Liquid | Transdermal | 7 g/100 mL | 2024 | |
Indications
| |||||
Dannso Corp. /d. b. a. Essential Products | Liquid | Topical | 17 mg/100 mL | 2024 | |
Indications
| |||||
Dongkou County Hecheng Network Technology Co. , Ltd. | Liquid | Topical | 10 g/100 mL | 2024 | |
Indications
| |||||
Hengyang Chuangjiujia Trading Co. , Ltd. | Liquid | Topical | 0.1 g/1 mL | 2024 | |
Indications
| |||||
Hengyang Chuangjiujia Trading Co. , Ltd. | Cream | Topical | 5 g/100 g | 2025 | |
Indications
| |||||
Medhome Pharma Inc | Liquid | Topical | 17 g/100 mL | 2025 | |
Indications
| |||||
Pharmaplast SAE | Plaster | Topical | 0.4 g | 2016 | |
Indications
| |||||
Scholls Wellness Company LLC | Liquid | Topical | 1.7 mg/10 mL | 2023 | |
Indications
| |||||
Shenzhen Bullfighting Trading Co. , Ltd. | Liquid | Topical | 17 g/100 mL | 2025 | |
Indications
| |||||
Shenzhen Haizhida E-commerce Co. , Ltd | Liquid | Topical | 17 g/100 mL | 2025 | |
Indications
| |||||
Shenzhen Hanchuan e-commerce Co. , Ltd | Liquid | Topical | 1 g/100 mL | 2024 | |
Indications
| |||||
Shenzhen Hengkaifeng Commerce and Trade Co. , Ltd | Liquid | Topical | 12 g/100 mL | 2025 | |
Indications
| |||||
Shenzhen Hengkaifeng Commerce and Trade Co. , Ltd | Liquid | Topical | 12 g/100 mL | 2025 | |
Indications
| |||||
Shenzhen Hengkaifeng Commerce and Trade Co. , Ltd | Liquid | Topical | 12 g/100 mL | 2025 | |
Indications
| |||||
Shenzhen Mengyue Technology Co. , Ltd. | Liquid | Topical | 17 g/100 mL | 2025 | |
Indications
| |||||
Shenzhen Mengyue Technology Co. , Ltd. | Patch | Topical | 40 g/100 1 | 2025 | |
Indications
| |||||
Shenzhen Zhenshangzekai Technology Co. , Ltd. | Ointment | Topical | 10 g/100 g | 2026 | |
| |||||
World Perfumes Inc | Solution | Topical | 17 g/100 mL | 2025 | |
| |||||
Shenzhen Finona Information Technology Co. , Ltd | Liquid | Topical | 0.05 g/1 mL | 2025 | |
Indications
| |||||
Shenzhen Finona Information Technology Co. , Ltd | Liquid | Topical | 0.05 g/1 mL | 2025 | |
Indications
| |||||
Premier Brands of America Inc. | Gel | Topical | 0.17 g/1 g | 2013 | |
Indications
| |||||
Guangzhou Hechuang Commercial Service Co. , Ltd. | Liquid |
| 8 g/100 g | 2026 | |
Indications
| |||||
Guangzhou Yilong Cosmetics. , Ltd | Liquid | Topical | 17 mg/100 mg | 2026 | |
| |||||
Shenzhen Earth Surface Trading Co. , Ltd. | Liquid | Topical | 12 g/100 mL | 2025 | |
Indications
| |||||
Shenzhen Earth Surface Trading Co. , Ltd. | Liquid | Topical | 12 g/100 mL | 2025 | |
Indications
| |||||
Hengyang Chuangjiujia Trading Co. , Ltd. | Patch | Topical | 0.4 g | 2025 | |
Indications
| |||||
Shenzhen Yangan Technology Co. , Ltd. | Patch | Topical | 40 mg/100 mg | 2024 | |
| |||||
Shenzhen Earth Surface Trading Co. , Ltd. | Patch | Topical | 12 g/100 1 | 2025 | |
Indications
| |||||
Shenzhen Hengkaifeng Commerce and Trade Co. , Ltd | Patch | Topical | 12 g/100 1 | 2025 | |
Indications
| |||||
Shenzhen Yangan Technology Co. , Ltd. | Patch | Topical | 1 mg/100 mg | 2024 | |
| |||||
Guangzhou ChuanMa International Trading Co. , Ltd. | Patch | Topical | 17 g/100 g | 2025 | |
| |||||
Hengyang Chuangjiujia Trading Co. , Ltd. | Patch | Topical | 0.1 g | 2025 | |
Indications
| |||||
Shenzhen Finona Information Technology Co. , Ltd | Patch | Topical | 0.03 g | 2025 | |
Indications
| |||||
Shenzhen Finona Information Technology Co. , Ltd | Patch | Topical | 0.12 g | 2025 | |
Indications
| |||||
Gaozhou Chapin Technology Co. , Ltd | Patch | Topical | 200 mg/1 g | 2024 | |
Indications
| |||||
Gaozhou Chapin Technology Co. , Ltd | Patch | Topical | 200 mg/1 g | 2024 | |
Indications
| |||||
Gaozhou Chapin Technology Co. , Ltd | Patch | Topical | 200 mg/1 g | 2024 | |
Indications
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Liquid | Topical | 18 g/100 mL | 2025 | |
Indications
| |||||
Ecommerce Digital Sales LLC | Liquid | Topical | 17 g/100 mL | 2026 | |
Indications
| |||||
FSA Store Inc. | Patch | Topical | 0.4 g/1 g | 2023 | |
Indications
| |||||
Meijer Distribution Inc | Patch | Topical | 400 mg/1 g | 2023 | |
Indications
| |||||
The Sisquoc Healthcare Corporation | Solution | Topical | 10 g/100 mL | 2019 | |
Indications
| |||||
BALBOA COMPANIES LLC | Cream | Topical | 50 mg/1 mL | 2021 | |
Indications
| |||||
Guangzhou Yixin Cross-border E-commerce Co. , Ltd. | Ointment | Cutaneous | 1 g/20 g | 2024 | |
Indications
| |||||
BALBOA COMPANIES LLC | Cream | Topical | 50 mg/1 mL | 2021 | |
Indications
| |||||
Balassa Laboratories Inc. | Stick | Topical | 0.4 g/1 g | 1983 | |
Indications
| |||||
Balassa Laboratories Inc. | Stick | Topical | 0.4 g/1 g | 2020 | |
Indications
| |||||
Jiangxi Yudexi Pharmaceutical Co. , LTD | Liquid | Topical | 17 g/100 mL | 2026 | |
Indications
| |||||
WINCO FOODS, LLC | Lotion | Topical | 20 mg/1 mL | 2020 | |
Indications
| |||||
Ningbo Rejoice International | Gel | Topical | 20 mg/1 mL | 2019 | |
Indications
| |||||
Rejoice International | Gel | Topical | 5 mg/237 mg | 2013 | |
Indications
| |||||
Zhejiang Dingtai Pharmaceutical Co. , Ltd | Plaster | Topical | 40 g | 2018 | |
Indications
| |||||
Skin Ai, LLC | Liquid | Topical | 0.2 g/20 mL | 2024 | |
Indications
| |||||
Skin Ai, LLC | Liquid | Topical | 2 g/100 mL | 2025 | |
Indications
| |||||
Skin Ai, LLC | Liquid | Topical | 0.2 g/20 mL | 2025 | |
Indications
| |||||
Focus Consumer Healthcare, LLC | Gel | Topical | 2 g/100 g | 2017 | |
Indications
| |||||
Shenzhen Deshijian Medical Equipment Co. , Ltd | Cream | Topical | 1.7 g/10 mL | 2025 | |
| |||||
ASA Universal Inc. dba: SONAGE | Gel | Topical | 1.5 g/100 mL | 2022 | |
Indications
| |||||
Brndxl LLC | Patch | Topical | 2 g/100 g | 2025 | |
Indications
| |||||
ZO Skin Health, Inc. | Patch | Topical | 20 mg/1 mL | 2024 | |
Indications
| |||||
ZO Skin Health, Inc. | Lotion | Topical | 1 mg/50 mL | 2024 | |
Indications
| |||||
Guchutang Biotechnology (Longyan) Co. , Ltd | Liquid | Topical | 6 g/100 mL | 2025 | |
Indications
| |||||
Guangzhou ChuanMa International Trading Co. , Ltd. | Liquid | Topical | 8 g/100 mL | 2025 | |
| |||||
Guangzhou ChuanMa International Trading Co. , Ltd. | Liquid | Topical | 8 g/100 mL | 2025 | |
| |||||
Repacked & Relabeled Product Labels
The table below lists products marketed under repackaged or relabeled National Drug Codes (NDCs).
Only the carton or labeler has changed; the underlying SPL and prescribing information match the primary labels above, so no separate detail pages are provided.
Below are the non-prescription pack sizes of Quick Action (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.
Label | Forms | Routes | Salicylic Acid | FDA year |
|---|---|---|---|---|
Private Label Skin Care | Cloth | Topical | 2 g/100 mL | 2025 |
Private Label Skin Care | Gel | Topical | 2 g/100 g | 2025 |
Private Label Skin Care | Liquid | Topical | 2 g/100 g | 2025 |